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EXECUTIVE SUMMARY
DEMOGRAPHICS (whole sample)
The HIV Futures New Zealand 2 survey was completed by 261 HIV positive people. 
75.7% were male (196), 23.9% were female (62), and one person was transgender. 60.7% were gay men, 22.7%
heterosexual women, 10.1% heterosexual men, 6.1% bisexual men, and 0.4% lesbian women.
The respondents’ ages ranged from 23 to 88 years with a mean of 45.6 years and a median of 44.0 years.
The majority of participants were New Zealand born (69.4%) and 89.8% of the participants spoke English at home,
with North African languages accounting for most of the remainder. Of the total sample, 255 indicated their ethnicity.
One hundred and seventy two were European/Pakeha (65.9%), 49 were African (18.8%), 17 were Maori (6.5%), nine
were Asian (3.4%) and five were Pacific Islanders (1.9%). 
HEALTH
HIV Antibody Testing
• 26.7% tested for HIV because they became ill
• 20.8% tested as part of routine health screening
• 8.4% tested because of a particular risk episode
• 7.9% tested because they were a member of a risk group
• 3.5% were tested without their knowledge
When asked about pre and post test counselling/discussion
• 25.8% had received pre-test counselling/engaged in pre-test discussion
• 22.0% of those testing positive in the last two years received pre-test counselling/engaged in pre-test discussion
• 66.8% received post-test counselling
• 79.6% of those testing positive in the last two years received post-test counselling
Pre and post test counselling was most often provided by medical personnel and respondents were generally
satisfied with the information and support received from this person.
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Current Health Status
77.2% rated their health as good or excellent and 75.1% rated their general well being as good or excellent.
Almost all PLWHA had taken a CD4/T-cell test and a viral load test. 21.6% of respondents had been diagnosed with
an AIDS defining illness, 14.3% in the last two years. 
HIV-related and other health conditions
24.9% of respondents indicated that they had experienced HIV-related illnesses. 29.8% indicated that they had a
major heath condition other than HIV/AIDS. The most common conditions reported were cardiovascular disease,
hepatitis C and asthma.
When asked if they had experienced any of the following conditions in the 
previous 12 months:
• 80.9% reported low energy or fatigue
• 64.2% experienced a sleep disorder
• 43.7% experienced confusion or memory loss
• 40.0% experienced weight loss 
• 34.7% reported experiencing lipodystrophy 
Mental Health
In the last six months 18.6% of respondents had taken prescribed medication for depression and 22.9% for anxiety.
28.8% had ever had a diagnosis of a mental health condition. 
25.1% of all respondents had ever been diagnosed with depression, 7.2% in the last two years.
Viral Hepatitis infections
• 11.1% had at some point had hepatitis A
• 54.3% had been vaccinated against hepatitis A
• 13.8% had at some point been diagnosed with hepatitis B, of whom:
• 60.9% had cleared the infection
• 26.1% had ongoing infection and
• one respondent had a chronic infection
• 57.4% had been vaccinated against hepatitis B
• 7.7% of respondents said they had been diagnosed with hepatitis C 
Prophylaxis
10.0% were currently taking prophylaxis for opportunistic infections.
TREATMENTS
Antiretroviral Therapy
Antiretroviral use:
• 72.9% were currently using ARV, most commonly two NRTIs, one NNRTI and one PI (54.1% of those on ARV,
N=79);
• 79.0% had used ARV at some time;
• 64.3% commenced ARV on the advice of their doctor;
• 73.6% of respondents were using a combination of three drugs;
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Difficulties of Taking ARV
• 44.3% of those participants currently taking ARV reported that they experienced difficulties taking them of which
the major problems were:
• 26.1% side effects
• 23.6% remembering to take the drugs on time;
• 16.6% transporting medication 
• 15.9% taking large numbers of tablets
• 12.7% taking medication in public
• 8.3% organising meals around the drugs
Attitudes to Antiretroviral Therapy
• 75.7% of respondents agreed that combination antiretroviral drugs mean better prospects for PLWHA
• 10.3% believed that it is still too soon to tell
• 26.0% agreed that combination antiretroviral drugs are harmful
• 19.8% agreed that the side effects outweigh the benefits of antiretroviral drugs
Treatment Breaks
• 32.5% of those currently on ARV had taken a break from ARV 
• The median length of break was one month
• Most breaks were taken for a combination of lifestyle and clinical reasons
• 65.3% consulted their doctors before a break 
• 87.5% consulted their doctors after a break 
• 45.2% saw their doctor before, during and after the treatment break
Antiretroviral Resistance
• 22.4% of those who had ever used ARV had taken a resistance test.
• 51.4% of those tested found resistance to one or more drugs
• 100% of those with resistance changed treatments
Dosing and Adherence
• 53.4% of the sample were taking ARV twice daily;
• 22.7% were taking ARV three times a day;
• 9.7% were taking ARV once a day.
• 92.4% had not missed a dose of ARV in the two days prior to completing the survey.
Clinical Trials
• 7.1% had participated in a clinical trial for HIV related treatment in the last two years
Complementary Therapies
• 47.0% used vitamin and mineral supplements
• 14.0% used herbal therapies
• 17.7% used marijuana for medicinal purposes
• Complementary therapies tended to be used in conjunction with allopathic treatment
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SERVICES
Health Services
• For HIV specific treatment 80.0% saw an HIV specialist at an outpatient clinic and 6.7% saw a doctor at a sexual
health centre. 
• For general health care, 52.1% of PLWHA saw a GP, 20.6% saw a GP with a high HIV caseload and 18.0% saw
an HIV specialist at an outpatient clinic.
• For 70.7% of respondents these were different doctors.
Respondents had used the following services in the six months prior to survey:
• 79.1% an HIV specialist in an outpatient setting 
• 55.8% a GP
• 21.9% a dentist
• 20.0% a GP with a high HIV caseload
Other Services
Services used at HIV/AIDS organisations:
• 34.4% treatment advice
• 30.7% counselling
• 20.0% social contact
• 20.0% peer support
• 12.1% complementary therapies
• 14.9% treatments information
Information
Important sources of information on treatments/HIV management:
• 83.3% HIV specialist at outpatient clinic
• 33.0% publications from HIVAIDS groups
• 29.8% internet
• 28.4% HIV magazine/newspaper
• 27.9% GP
• 21.9% treatments-specific NZAF staff
• 25.1% GP with high HIV caseload
• 24.7% HIV specialist nurse
• 20.9% HIV positive friends
Important sources of information on living with HIV:
• 37.7% HIV specialist at outpatient clinic
• 32.6% publications from HIVAIDS groups
• 32.6% HIV positive friends
• 28.8% HIV magazine/newspaper
• 28.4% Body Positive staff
• 27.0% treatments-specific Body Positive staff
Publications
Gay and HIV press were accessed by sizable proportions of the sample, as were HIV community publications.
Involvement with HIV/AIDS Organisations
62.4% had some contact with HIV/AIDS organisations, mostly receiving newsletters (78.2%) or being clients of these
organisations (60.9%). 4.5% were employees of HIV/AIDS organisations.
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THE SOCIAL WORLD OF PLWHA
Contact with Other PLWHA
• 79.5% knew another PLWHA
• 41.9% had HIV-positive acquaintances 
• 11.6% had an HIV-positive spouse/partner 
• 55.5% spent at least some time with other PLWHA
• 8.5% spent a lot of time with other PLWHA
• 44.5% spent no time with other PLWHA
• 16.0% had been involved with the care of someone with HIV/AIDS
• 38.1% said someone close had died of AIDS related causes
For 55.9% of respondents HIV was an important part of their identity, while for 14.2% it was an essential part. HIV
status tended to be less important than identities based on sexuality, gender or family.
Disclosure
Almost all respondents (95.3%) had disclosed their HIV status to at least one person, generally partners, close
friends and family. 
For 47.7% of respondents, their HIV status had been disclosed to another person when they did not want it to be
(19.0% in the last two years).
Social Support
Sources of ‘a lot’ of social support:
• 78.0% partners/spouse;
• 51.4% PLWHA groups;
• 51.3% close friends;
• 46.5% parents;
Planning for the Future
19.9% planned only one day at a time, while 60.2% planned at least one year ahead.
Relationships and Sex
• 31.9% of PLWHA were not having sex at present 
• 42.5% of PLWHA were in a regular relationship
• 16.2% had a regular partner and had sex with casual partners 
• 25.0% of respondents had casual partners only
Of those in a regular relationship, 27.6% had a partner who was also HIV positive, 65.3% had an HIV negative
regular partner and 7.1% a partner of unknown status. Nearly all PLWHA (97.9%) had disclosed their status to their
regular partner, either when they were diagnosed, or at the commencement of the relationship. 
40.4% of the respondents reported having anal or vaginal intercourse with a regular partner in the previous six
months. Condom use with regular partners was strongly related to the HIV-status of the partner. 
51.7% of the sample reported having sex with casual partners in the past six months. Most male respondents
reported always using condoms with casual male partners.
49.3% of the sample provided information about the most recent episode of sex with a casual partner in the
previous six months. Vaginal or anal intercourse took place in 70.5% of these instances. 
Condom use with the most recent casual partner:
• 100.0% (n=9) of those who had sex with an HIV+ partner 
• 66.7% (n=4) of those who did not know their partner’s HIV status 
• 89.7% (n=52) of those who had sex with an HIV negative partner
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26.7% of PLWHA said they would prefer to be in a relationship with someone who is also HIV positive. 58.9% of
PLWHA expressed some fear of rejection from potential partners due to disclosing their HIV status. The majority of
PLWHA (65.5%) felt HIV had a negative effect on their sexual pleasure.
Only 6.7% of PLWHA agreed with the statement I feel more confident about unprotected sex because of the new
treatments. 
Very few PLWHA agreed that undetectable viral load meant that HIV was unlikely to be transmitted (10.3%).
However, 20.2% of PLWHA agreed with the statement If there was a vaccine which prevents HIV I would not practice
safe sex.
Legal Issues around disclosure of HIV status
63.1% agreed that it is legally OK for someone to use a condom for anal or vaginal sex and not to tell their partner
about HIV status.
61.1% of respondents disagreed that it is legally OK for a person to disclose their HIV status to a partner and then
not use a condom for anal or vaginal sex.
Recreational Drug Use
Alcohol was the drug most commonly used by PLWHA (75.3%), while 37.7% had used tobacco in the previous 12
months. 84.8% of respondents reported that they had never injected illegal drugs and of those who had injected
illegal drugs only 23.8% had done so in the last 12 months. Of PLWHA who reported injecting drugs, none had
shared injecting equipment in the past twelve months. 
11.1% of respondents reported having missed a dose of ARV at some point as a result of using illegal drugs and
4.4% reported having had a bad experience as a result of using both illegal drugs and ARV.
HOME, WORK & MONEY
Accommodation
• 30.7% were living in private rental accommodation
• 45.6% owned or were purchasing a house or flat
• 13.0% were living in public rental accommodation (government owned)
• 6.5% lived rent-free (e.g. provided by friends, family, etc.)
88.7% of respondents stated that their accommodation was suitable for their current needs. Of those who said their
accommodation was unsuitable, the main reasons given were that it was too small or too expensive.
• 29.8% of PLWHA lived by themselves
• 50.9% of PLWHA lived with pets
• 81.9% of respondents had access to a car
23.3% had ever changed their accommodation as a result of having HIV/AIDS, 9.3% in the last two years.
Employment
Over half of respondents were in paid employment (61.7%), the majority of these being in full-time work (43.9% of
total sample). The majority of the remainder described themselves as either unemployed, not working or retired.
Most respondents (62.9%) said they had either left their career or in some way reduced their career goals as a result
of their HIV diagnosis. 
Impact of antiretroviral therapy on employment:
• 12.8% stopped work;
• 13.5% anticipated a longer time in the workforce;
• 5.8% went back to work.
41.5% of respondents had stopped work at some time in the past for reasons related to having HIV/AIDS. Poor
health and diminished energy levels were the most commonly cited reasons for this. 
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Of those respondents who had left work, 66.2% had returned to work and this was most commonly for financial
reasons. 
Around two-thirds of respondents who were working said that HIV has had an impact on their capacity to perform
their work duties. Most commonly respondents reported that they tired more quickly, that they had difficulty
concentrating and that they had to reduce their work hours. 
50.8% of PLWHA currently in work had not disclosed their HIV status to anyone at their workplace, while 12.6% did
not try to keep their HIV status confidential. The most common difficulties for those wanting to maintain
confidentiality at work were gossip, visible signs of illness and explaining absences from work.
Finances
Just under half of respondents (45.7%) identified their main source of income as salary, while around one-third
relied on government pensions or benefits (35.6%). The median weekly in-hand income for respondents was $486.
Median incomes were lower than New Zealand National averages, but had increased since the first survey at a rate
greater than the Consumer Price Index. 
Items that respondents found it somewhat or very difficult to pay for were:
• 56.4% clothing
• 50.3% utilities
• 53.4% housing
• 46.5% food
• 51.8% transport
34.6% (n=53) of those on a government benefit had been assessed by a WINZ Medical Officer in the past 2 years.
24 respondents said that it had caused them distress, while 22 said that the conditions of their benefit had changed.
Financial Hardship
Compared with those in the top quartile of the income distribution, those in the bottom quartile were less likely to
be in paid employment and more likely to have a government benefit as their primary source of income. This group
also rated their overall health and well-being worse and experienced significantly greater difficulty paying for food,
housing and utilities. 
Discrimination
3.8% experienced less favourable treatment in relation to accommodation, 1.9% in the last two years
22.4% experienced less favourable treatment because of HIV in relation to health services, 11.0% in the last two
years
Four Hepatitis C co-infected respondents experienced less favourable treatment because of Hepatitis C in relation
to health services.
25.9% of respondents had experienced less favourable treatment in relation to insurance, 10 in the last two years.
14.0% of respondents had experienced less favourable treatment in the workplace as a result of having HIV, 5.8%
in the last two years.
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PARTICIPANTS OF AFRICAN DESCENT
Health
Pre-test counselling/discussion was rare in this sample and half reported receiving post-test counselling. Most
respondents reported that their current health and well being was good or excellent. Almost all respondents had
regular CD4 and viral load tests. Median viral load was at an undetectable level. AIDS defining illnesses, HIV related
illnesses and other major health conditions were reported by few of the respondents. 
Treatments
Thirty respondents (70%) had used ARV at some point, and twenty six (61%) were currently using these treatments.
The most common combination was 2 NRTIs and 1 NNRTI (10 of those on ARV). There were few reports of
difficulties taking ARV. Most respondents reported some concern over the future efficacy of their treatments.
Services
Hospital-based HIV specialists were the primary providers of HIV specific and general treatment for a large majority
of respondents. Few participants in this population used any of the services listed in the survey, either at HIV/AIDS
organisations or at other organisations. Clinical sites were the most commonly reported source of information in
relation to HIV management, and few reported seeking information on issues concerned with living with HIV. 
The social world of PLWHA
54% did not personally know anyone else with HIV.
40% have had someone close to them die from HIV/AIDS. 20% spent at least some time with other positive people.
17% had not disclosed their HIV status to anyone.
Participants were most likely to have nominated their health care workers as providing social support. 
Relationships and Sex
54% were currently in a regular relationship. Of those, 43% (n=9) reported that their partner was also HIV positive.
Most respondents reported consistent condom use with regular partners. 33 participants had children. 
Accommodation
Twelve respondents were living in private rental accommodation, while twenty-nine (63%) lived in public rental
accommodation. Only four owned or were purchasing a home.
Employment
Twenty four respondents (52.2%) were currently employed, with eighteen being in full-time work and six in part-time
work. 21 of the 24 working said no-one in the workplace knew that they were HIV positive. 
Finances
Twenty-one participants were receiving a salary and seventeen had a government pension or benefit as their main
source of income. The median weekly in-hand income was $380. Participants in this group reported higher rates of
difficulty in paying for the costs of items in all categories compared with other PLWHA. 
Discrimination
Six respondents had experienced less-favourable treatment at a medical service as a result of having HIV, all in the
previous two years. Two respondents indicated that they had experienced less favourable treatment in relation to
accommodation. Six respondents indicated that they had experienced less favourable treatment in relation to
insurance. Two respondents had experienced less-favourable treatment in the workplace. 
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KEY COMPARISONS
WITH HIV FUTURES
NEW ZEALAND 2001
HEALTH
HIV Antibody Testing
A higher proportion of respondents reported having received pre-test counselling or engaging in a pre-test
discussion than in 2001. This includes those testing positive in the two years prior to survey, where this increased
from 6% to 22%. Post-test counselling rates remained the same. 
Current Health Status
General ratings of health status and well being were similar across the two surveys. A greater proportion of
respondents had been diagnosed with an AIDS defining illness in the two years prior to survey in 2007 than in 2001
(14% vs 5%). 
HIV-related and other health conditions
A smaller proportion of respondents reported HIV related illnesses (2001: 36%, 2007: 25%).
Mental Health
In 2007 a slightly smaller proportion of respondents reported taking antidepressant medication in the prior six
months (2001: 23%, 2007: 19%) while a greater proportion reported taking anti-anxiety medication (2001: 15%,
2007: 23%).
Viral Hepatitis
Vaccination rates were higher for hepatitis A (2001: 44%, 2007: 54%) and hepatitis B (2001: 48%, 2007: 57%).
Lifetime diagnoses were slightly lower for hepatitis A (2001: 14%, 2007: 11%) and hepatitis B (2001: 18%, 2007:
14%). Hepatitis C rates were similar. 
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TREATMENTS
Antiretroviral Therapy Use
Similar proportions of respondents had ever used antiretroviral treatments (2001: 78%, 2007: 79%), while current
use was slightly higher (2001: 64%, 2007: 73%).
A smaller proportion of PLWHA reported having difficulties using these treatments (2001: 79%, 2007: 44%). This
was reflected in lower proportions reporting side-effects (2001: 44%, 2007: 26%) and difficulties with drug timing
(2001: 44%, 2007: 24%). 
Attitudes to Antiretroviral Therapy
Overall, the profile of attitudes to antiretroviral treatment was similar. 
Treatment Breaks
Similar proportions of respondents in the two studies had ever taken a break from antiretroviral treatments. The
median length of the most recent break was shorter (2001: 45 days, 2007: 28 days). Respondents were more likely
to have discussed this break with their doctor before taking it (2001: 43%, 2007: 65%). 
Antiretroviral Resistance
A slightly higher percentage of people had undergone resistance testing in the most recent survey (2001: 19%,
2007: 22%). However, a smaller proportion reported that testing had identified resistance to any treatments (2001:
74%, 2007: 51%). 
Dosing and Adherence
A smaller proportion of participants reported taking antiretroviral medication twice daily (2001: 66%, 2007: 53%)
while a higher proportion reported taking treatment three times per day (2001: 9%, 2007: 23%). 
Adherence, measured by the proportion not missing any doses in the two days prior to survey, was slightly higher
in the most recent survey (2001: 80%, 2007: 92%).
Complementary Therapies
Use of complementary therapies was similar across the two surveys, although in 2007 more reported taking vitamin
or mineral supplements (2001: 30%, 2007: 47%). 
SERVICES
Health Services
A higher proportion of PLWHA reported seeing an HIV outpatient specialist as their primary HIV physician in 2007
(2001: 77%, 2007: 80%). A slightly lower proportion saw a different doctor for HIV specific and general health care
(2001: 74%, 2007: 71%). Slightly fewer had visited an outpatient HIV specialist in the six months prior to survey
(2001: 82%, 2007: 79%). 
Other Services
Generally, service use was lower across all services at HIV organisations and other organisations in the most recent
survey. For example, at HIV/AIDS organisations: treatments advice (2001: 55%, 2007: 34%); treatments information
(2001: 26%, 2007: 15%); and counselling (2001: 48%, 2007: 31%).
Information
Participants cited similar organisations and sites as important sources of information in the two surveys. There were
slight differences in the proportions citing HIV magazines and newspapers (2001: 32%, 2007: 28%) and internet
sources (2001: 24%, 2007: 30%). 
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Involvement with HIV/AIDS Organisations
Fewer had contact with HIV/AIDS organisations (2001: 77%, 2007: 62%), although the type of contact was
consistent across surveys. 
THE SOCIAL WORLD OF PLWHA
Contact with Other PLWHA
A slightly smaller proportion of respondents reported that they knew other PLWHA (2001: 84%, 2007: 80%) and a
slightly higher proportion said they spent no time with other positive people (2001: 40%, 2007: 45%). A smaller
proportion had been involved in the care of someone else with HIV (2001: 22%, 2007: 16%), and a smaller
proportion also said that someone close to them had died of HIV/AIDS (2001: 70%, 2007: 62%). 
Disclosure
Disclosure of HIV status to others was similar across the two surveys. A smaller proportion reported ever
experiencing unwanted disclosure (2001: 54%, 2007: 48%) and unwanted disclosure in the previous twelve months
(2001: 33%, 2007: 19%).
Social Support
Patterns of social support differed somewhat between the two surveys. Similar proportions reported ‘a lot’ of
support from partners (2001: 80%, 2007: 78%) and close friends (2001: 53%, 2007: 51%), while more reported this
for PLWHA groups (2001: 13%, 2007: 52%).
Planning for the Future
The percentage of respondents reporting that they planned only one day at a time had decreased slightly (2001:
25%, 2007: 20%) and the proportion planning more than one year in the future had increased (2001: 55%, 2007:
60%). 
Relationships and Sex
A slightly lower percentage reported having no sexual relations at present (2001: 40%, 2007: 32%). Similar
percentages were in regular relationships (2001: 41%, 2007: 43%). Slightly more reported casual partners plus a
regular relationship (2001: 13%, 2007: 16%) or casual partners only (2001: 23%, 2007: 25%). 
A smaller proportion said they would prefer a relationship with someone who is also HIV positive (2001: 34%, 2007:
27%). Similar patterns were observed regarding the impact of HIV on sexual relationships and sexual pleasure. A
considerably smaller proportion of participants reported that they would not practice safe sex if a vaccine became
available (2001: 70%, 2007: 20%).
Slightly more of those in regular relationships had an HIV positive partner (2001: 21%, 2007: 28%). Larger
proportions reported having anal or vaginal sex with their regular partner in the previous six months (2001: 29%,
2007: 40%). 
A higher proportion of respondents reported having sex with a casual partner in the previous six months (2001: 36%,
2007: 52%). 
Most recent casual partner
A higher proportion of participants provided data on their most recent casual partner in the six months prior to
survey (2001: 22%, 2007: 49%). Fewer of these sexual episodes involved anal or vaginal sex (2001: 89%, 2007:
71%). Patterns of condom use with most recent casual partner were, however, the same. 
Legal Issues around disclosure of HIV status
There were some noticeable changes in the response to items concerning the legal issues around disclosure. A
considerably higher proportion of participants agreed with the statement it is legally OK for someone to use a
condom for anal or vaginal sex and not to tell their partner about HIV status (2001: 38%, 2007: 63%), while a smaller
proportion agreed with the statement it is legally OK for a person to disclose their HIV status to a partner and then
not use a condom for anal or vaginal sex (2001: 70%, 2007: 61%). 
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Recreational Drug Use
Rates of recreational drug use were similar between the two surveys, with the exception of tobacco use (2001: 46%,
2007: 38%)
HOME, WORK & MONEY
Accommodation
A greater proportion of participants owned or were purchasing their own home in the most recent survey (2001:
37%, 2007: 46%). More were also in private rental accommodation (2001: 28%, 2007: 31%) and fewer were in public
rental accommodation (2001: 18%, 2007: 13%). A higher percentage reported that their current accommodation
was suitable for their needs (2001: 78%, 2007: 89%). A higher percentage of participants lived by themselves (2001:
30%, 2007: 37%) and with pets (2001: 51%, 2007: 59%) and had access to a car (2001: 75%, 2007: 82%). 
Employment
In 2007 a higher proportion of participants reported being in paid employment (2001: 53%, 2007: 62%), particularly
in full time employment (2001: 38%, 2007: 44%). Among those working, more reported that HIV had an impact on
their capacity to perform their work duties (2001: 44%, 2007: 67%). Smaller proportions of respondents reported
that they had disclosed their HIV status to at least one person in their workplace (2001: 54%, 2007: 49%), and that
they did not try to keep their HIV status confidential at work (2001: 22%, 2007: 13%). 
Finances
A considerably greater percentage of respondents reported their main source of income as a salary (2001: 39%,
2007: 46%) and less reported this as a government benefit (2001: 47%, 2007: 36%). Median weekly personal
income has increased (2001: $330, 2007: $486), and this is greater than the change in consumer price index (HIV
Futures 47.2%, NZ CPI + 16.4%) indicating that there has been an increase in the purchasing power of this
population. Median income, however, remains lower than the remainder of the New Zealand population. 
Difficulty paying for goods and services has reduced between the two surveys. The proportion reporting that it is
somewhat or very difficult to pay for basic needs is lower in the most recent survey: clothing (2001: 66%, 2007:
56%); utilities (2001: 63%, 2007: 50%); housing (2001: 60%, 2007: 53%); food (2001: 54%, 2007: 47%); transport
(2001: 55%, 2007: 52%). While these changes are in a positive direction, it should be noted that there is still
considerable financial hardship for PLWHA.
A smaller percentage of respondents on a government benefit reported that they had received an assessment from
a WINZ medical officer (2001: 62%, 2007: 35%). 
Discrimination
Fewer reported experiencing less favourable treatment in relation to accommodation (ever 2001: 12%, 2007: 4%),
(two years prior 2001: 5%, 2007: 2%). 
Fewer reported experiencing less favourable treatment at health services (ever 2001: 31%, 2007: 22%), (two years
prior 2001: 20%, 2007: 11%). 
Fewer reported experiencing less favourable treatment in relation to obtaining insurance (ever 2001: 36%, 2007:
26%). 
PARTICIPANTS OF AFRICAN DESCENT
Caution must be exercised when comparing the findings on refugees in the 2001 report and those of African
descent in the current report. While the populations are similar, the criteria for inclusion are somewhat different in
the two reports (see page 71). 
Overall circumstances appear to have improved for this population. People were more likely to be in employment
and were earning more. However, this group is still disadvantaged in comparison to other PLWHA and the New
Zealand population. Access to health care services remained high, as did reliance on clinical services for
information and support. Disclosure of HIV status remained low. 
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INTRODUCTION
Here, for the second time, we are given a privileged insight into the lives of people living with HIV in this country. In
the pages that follow you are offered a rare opportunity to see some of the complexity and diversity of individual
and collective experiences of being HIV positive. People from around the country have provided details of their
histories, their daily lives, their hopes and fears. This is not something that people have done lightly - completing
this survey requires commitment, courage and honesty. It asks that people relive some of the darkest times in their
lives and to share with us things they may have never shared with the people closest to them. It asks people to
stand up and be counted among the positive people of New Zealand. And it asks you to take notice. These lives
are presented to you, not for your interest, not out of obligation, not just so they are documented, not just so you
care. These lives are presented to you with the expectation that you will respond - that you will take action. There is
a responsibility that comes with reading this report, just as there is a responsibility with conducting this study.
Whatever your relationship to the community of HIV positive people in this country, whether you are in government,
service provision, policy development, whether you are a clinician, a researcher, a friend, a partner, a person with
HIV, whether you have lived through many years of this pandemic or have recently found yourself in its midst, this
report demands that you act. It demands that you work to counter the disadvantages and that you work to preserve
the hard won achievements. This is a time to take stock. This is a time to ask: What have we achieved since the
first time we were told these things? What do we want to hear, when in five years time we hear them again? What
do we want that story to be? Will our actions have made this a better story?
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DEMOGRAPHICS
This section provides an overview of the sample characteristics of the HIV Futures New Zealand 2 sample. 
Sample Demographics
The HIV Futures New Zealand 2 survey was completed by 261 HIV positive people. Of the total respondents, 77.8%
completed a paper copy of the survey, while 22.2% completed the survey on-line (see Appendix A on page 86 for
a comparison of these two samples).
There is no register of HIV positive New Zealanders, as HIV testing is voluntary and anonymous and HIV is not a
notifiable condition in New Zealand. Recently the AIDS Epidemiology Group at the University of Otago has provided
an updated estimate of the number of people living with diagnosed HIV in this country. Based on antiretroviral
therapy use recorded by Pharmac, and information from the Infectious Disease Unit at Auckland District Health
Board, the AEG estimates that as of the end of 2007 there were 1230 individuals living with diagnosed HIV in New
Zealand (AEG 2008). 
Given this estimate, the sample recruited for this study represents approximately 21% of the diagnosed HIV positive
population.  
There is limited information in New Zealand on the demographic characteristics of people diagnosed with HIV prior
to 1996. However, since 1996 the information available about new HIV diagnoses has expanded. Individuals who
were diagnosed between 1.1.96 and 30.11.07, and who were still believed to be living in New Zealand (i.e. were not
believed to have died or have moved overseas) can provide us with a snapshot against which the HIV Futures New
Zealand 2 sample can be compared (AEG 2007). 
Of the survey respondents, 75.7% were male (196), 23.9% were female (62), and one person was transgender. This
sample consisted of 60.7% gay men, 22.7% heterosexual women, 10.1% heterosexual men, 6.1% bisexual men,
and 0.4% lesbian women. The AEG estimates the gender breakdown of the current HIV positive population
diagnosed since 1996 to be 78.4% male and 21.6% female (AEG 2007). 
Respondents ranged in age from 23 to 88 years with a mean of 45.6 years and a median of 44.0 years.
The majority of participants were New Zealand born (69.4%) and 89.8% of the participants spoke English at home,
with East African languages accounting for most of the remainder. Of the total sample, 255 indicated their ethnicity.
One hundred and seventy two were European (65.9%), 49 were African (18.8%), 17 were Maori (6.5%), nine were
Asian (3.4%) and five were Pacific Islanders (1.9%). This is generally consistent with the AEG figures since 1996
which suggest the population consists of 49.8% European/Pakeha, 23.7% African, 10.9% Asian, 7.5% Maori, 2.8%
Pacific Islander and 5.2% other/unknown (AEG 2007). 
Respondents came from all regions of New Zealand, with the majority coming from the Auckland area. Again this
is reasonably consistent with AEG figures since 1996 which indicate that 51.1% of the HIV infected population live
in Northland and Auckland. 
TABLE 1 Respondents’ place of residence
Area Frequency Percent of Sample
Auckland 141 54.4
Wellington 30 11.6
Christchurch 23 8.9
Hamilton 6 2.3
Other city 16 6.2
Provincial Town 20 7.7
Rural 23 8.9
65.8% of participants were living in the same area in which they were diagnosed with HIV infection, while the
remainder were living in a different area.
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Table 2 below shows the years in which respondents tested HIV positive and in which they believe they were
infected with HIV. Overall these patterns match those of the New Zealand epidemic. The time difference between
year of presumed infection and year of diagnosis ranged from 0 to 25 years with a mean of 2.7 years and a median
of one year. 31.6% of the sample tested positive in the same year they believe they were infected. There are 51
respondents in the sample who had tested positive in the two years prior to survey and 8 respondents who believe
they were infected in the previous year.
TABLE 2 Year of respondents’ HIV diagnosis and presumed year of infection
Year Tested HIV Positive Presumed Infected
Pre 1985 2.3 13.5
1985-1989 10.8 13.5
1990-1994 13.5 20.2
1995-1999 21.9 19.7
2000-2004 31.9 21.2
2005+ 19.6 11.9
81 respondents (32.3%) indicated that they were atheist/agnostic, 53.9% indicated mainstream religious
identification and the remainder indicated that they either had ‘other’ (10.4%) or New Age (3.6%) spiritual beliefs.
Less than one third of respondents (30.3%) indicated that religious beliefs were not important to them, while a
similar proportion (26.0%) indicated that these were of little importance, 21.3% that they were very important and
22.4% that they were extremely important. Data from the New Zealand Census indicate that 32.2% of the population
had no religious beliefs (Statistics New Zealand).
The educational level of respondents was somewhat higher than the general population, as is usual in research
requiring a moderate level of literacy and engagement with the research process. New Zealand census data
indicates that 14.2% had graduate or post-graduate education (Statistics New Zealand). The participants’
educational levels are shown in Table 3 below.
TABLE 3 Educational level of respondents
Level Frequency Percent of sample
Graduate or postgraduate degree 32 12.5
Bachelors or undergraduate degree 39 15.2
Professional/technical/trades certificate or diploma 64 25.0
HSC, UE, Bursary or NCEA level 3 20 7.8
6th form certificate, NCEA level 2 30 11.8
School certificate, NCEA level 1 38 14.8
No school qualification 33 12.9
NOTE ON THE ANALYSIS IN FOLLOWING SECTIONS.
The analyses from this point forward are divided into two populations. The responses of HIV positive New
Zealanders of African descent are analysed separately in the section commencing on page 71. This recognises the
particular experiences of this population and allows a meaningful comparison with findings presented in the first
HIV Futures New Zealand report. The analyses of the remainder of the sample are presented in the following
sections. Where appropriate and where sample sizes permit, comparison is made between specific populations
within sections. Often the sub-populations of respondents become too small for comparison, particularly when
there are a number of response categories. In these cases, sub-population comparisons are likely to be misleading
and are not included. 
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This section of the report deals primarily with the physical health and experience of health of New Zealand
PLWHA. The chapter includes a discussion of the experiences of testing positive for HIV, the current health
status of participants measured both by clinical markers and self-reported health and well being, the health
burden in terms of concomitant health conditions and health maintenance strategies. 
HIV ANTIBODY TESTING
HIV antibody testing in New Zealand is available from general practitioners and HIV specialists, sexual health clinics
and New Zealand AIDS Foundation regional centres. This service is provided free in the latter three settings, and
anonymously through NZAF. Rapid testing became available through the New Zealand AIDS Foundation in
December 2006. Viral load and resistance testing has been available in New Zealand since 1996 and can be
ordered by specialist clinicians through four laboratories. Counselling before or after an HIV test is not legally
required, although it is strongly recommended in the health practitioner guidelines (Ministry of Health, 2004). These
guidelines also detail the best practice procedures for pre-test discussion and post-test counselling. 
Reporting of HIV diagnoses is not mandatory in New Zealand, however demographic information relating to a
positive diagnosis is sought through a system of “enhanced surveillance” involving laboratories, the clinician who
requested the test and the AIDS Epidemiology Group (Paul et al., 2000). AIDS is a notifiable disease and is thus
reportable by law to the local Medical Officer of Health (Ministry of Health 2004). We asked respondents about the
circumstances surrounding the time that they tested positive for HIV.
As can be seen from Table 4, 26.7% of the respondents had taken the test as a result of illness, 20.8% as part of
routine health screening and 8.4% as a result of a particular risk episode. Gay or bisexual men were more likely to
say that they tested as a result of illness (28.8%) compared with 17.2% of women and 12.5% of heterosexual men.
Only gay or bisexual men gave the reason ‘Member of risk group’ (10.6%). The reason ‘My partner tested positive’
was more likely to be given by women (17.2%) than by gay or bisexual men (9.4%) or heterosexual men (none). 
Of those who had tested positive in the last two years, 32.6% had taken a test due to illness, while 25.6% said they
were tested as part of a routine health screening and 11.6% because of a particular risk episode.
TABLE 4 Reasons for testing
Reason Frequency Percent
Became ill/ongoing illness 52 25.7
Routine health screening 35 17.3
Particular risk episode 21 10.4
Partner tested positive 20 9.9
Other 20 9.9
Member of risk group 16 7.9
Doctor’s suggestion 15 7.4
Tested without knowledge 7 3.5
Starting new relationship 6 3.0
Antenatal 3 1.5
Contact tracer/other health worker’s suggestion 2 1.0
Pre- and Post-Test counselling/discussion
The experience of HIV testing and the receipt of a positive diagnosis can be highly emotionally charged events.
Those providing testing for HIV must be aware of the practical, informational and emotional needs of those taking
the test, even when this is something they have done on a number of occasions. Pre-test discussion provides an
opportunity to clarify their knowledge around transmission and the technical aspects of the test itself (for example,
window periods, specificity, costs). There may also be discussion of the events that led to testing, ongoing concerns
about maintaining protective behaviours, imagined consequences of receiving a positive result, managing
relationship issues and managing the period while waiting for test results. Post-test counselling when the test is
positive is often not a single event but a process that includes a number of consultations and referrals to address
health, emotional and social support issues. In New Zealand, there are guidelines for those providing HIV testing
that outline the key issues that need to be considered before and after testing for both those who test negative and
those who test positive (Ministry of Health 2004). Clearly the needs and responses of individuals vary enormously
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on receipt of a positive test result, and practitioners need to be able to tailor their response to these. The
introduction of rapid testing has provided additional challenges in this regard, where an interim positive rapid test
needs confirmation through full blood Western Blot testing. The blood test may confirm or contradict the rapid test,
leading to a degree of uncertainty. 
We asked respondents if they had received pre- and/or post-test counselling at the time they tested positive, who
provided this counselling and how satisfied they were with the information and support they received at the time.
25.8% of respondents indicated that they had received pre-test counselling or engaged in an HIV test discussion.
Of those who had tested positive in the last two years, 22.0% had received pre-test counselling. The counselling
was generally provided by a doctor (28.0%), and less commonly by staff at an HIV/AIDS organisation (24.0%), a
counsellor (18.0%) staff at a sexual health clinic (10.0%), or a doctor and a counsellor (6.0%). No other response
accounted for more than 5% of responses. When asked if they were satisfied with the counselling/discussion, 86.4%
reported they were satisfied with the information they received from this person and 85.9% said they were satisfied
with the level of support they received. 
66.8% of respondents indicated that they had received post-test counselling. Of those who tested positive in the
last two years 79.6% had received post-test counselling, a significantly greater proportion than for those who were
diagnosed earlier than this. The counselling was generally provided by a doctor (36.0%), but was also commonly
provided by staff at an HIV/AIDS organisation (25.7%) a counsellor (16.9%) or a nurse (6.6%). No other response
accounted for more than 5% of responses. When asked if they were satisfied with the counselling they received,
89.6% said they were satisfied with the information they received and 83.8% said they were satisfied with the
support they received.
CURRENT HEALTH STATUS
Experience of Health and General Well-Being
We asked respondents how they would best describe their current state of physical health and overall sense of well-
being on a four point scale. The results are shown in Table 5 and Table 6 below. Half of the sample (50.2%) rated
their physical health as good and 27.0% as excellent. There were no significant gender differences in the ratings of
health and well-being. 
TABLE 5 Respondents’ self ratings of general health status
Frequency Percent
Poor 9 4.2
Fair 40 18.6
Good 108 50.2
Excellent 58 27.0
The ratings for well being were of a similar pattern to those for health. Three-quarters of respondents (75.1%) rated
their well-being as either good or excellent, while 20.7% rated this as fair and 4.2% as poor. 
TABLE 6: Respondents’ self ratings of general well-being
Frequency Percent
Poor 9 4.2
Fair 44 20.7
Good 101 47.4
Excellent 59 27.7
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FIGURE 1 Self rated Health FIGURE 2 Self rated well-being
When we look at the relationship between these two measures, we can see overall that better health was related to
greater well-being (see Table 7). This is, however, not a clear and direct relationship. The correlation between the
two measures is p=0.696 (p<0.001). Some respondents (16.4%) rated their well-being as worse than their health
and 14.6% rated their health as worse than their well-being. Having a higher CD4 count at the most recent test was
associated with having better health (x 2 (6, N=178) = 13.80, p<0.05), however was not significantly associated
with better overall well-being (x 2(6, N=176) = 11.49, p=0.074). However there was no correlation between health
and most recent viral load result, or between well-being and most recent viral load. 
TABLE 7 Relationship between ratings of overall health and well-being (% of total sample)
HEALTH
Wellbeing Poor Fair Good Excellent   
Poor 1.9 1.4 0.9 -
Fair 1.4 11.7 7.5 -
Good 0.5 5.6 34.7 6.6
Excellent 0.5 - 6.6 20.7
CD4 and Viral Load
As with the previous three surveys, almost all PLWHA had taken a CD4/T-cell test (96.7%) and a viral load test
(94.4%). Most respondents had taken their most recent CD4 test in the six months prior to survey (87.5%) (56.1%
in the last three months) and their most recent viral load test in the six months prior to survey (82.1%) (50.3% in the
last three months). On average participants had taken three viral load tests in the preceding twelve months. Among
those PLWHA who had taken a CD4 test, 93.0% reported that they have at some time had a CD4 count of less then
500 cells/µl and 64.0% reported a count of less than 250 cells/µl. 
Results for PLWHA’s most recent CD4/T-cell test ranged from 10 to 1190 cells/µl with a mean of 521.61 cells/µl and
a median of 480.00 cells/µl.
Among those PLWHA who have taken a viral load test, 54.1% reported that at some point they have had a result of
over 10,000 copies/ml and 38.8% a result of over 50,000 copies/ml. 
Results for PLWHA’s most recent viral load test ranged from below detectable levels to 10,000,000 copies/ml with
a mean of 68,466 copies/ml and a median of below detectable level. Table 8 shows the combined CD4 and viral
load results of the sample. The results are grouped by three levels of CD4 count: little damage (500+), moderate
damage (250-499) and severe damage (0-249), and four levels of viral load: below detectable levels (<500), low
(500-9,999), moderate (10,000-49,999) and high (50,000+). As different assays would have been used to assess
the respondents’ viral loads we have defined below detectable levels as being those responses that were less than
500 copies/ml and those where the respondent wrote in zero or below detectable level.
Excellent 27.0% Excellent 27.7%
Poor 4.2%Poor 4.2%
Fair 18.6% Fair 20.7%
Good 47.4%
Good 50.2%
TABLE 8 Results of most recent serological tests, (percentage of total sample)
HIV VIRAL LOAD
<500 500-9999 10000-49999 50000+ Total 
Cd4/T-cell 500+ 37.1 3.6 3.0 0.6 44.3
count 250-499 36.5 2.4 3.0 2.4 44.3
0-249 10.2 - - 1.2 11.4
Total 83.8 6.0 6.0 4.2 100
HEALTH CONDITIONS
While there is often uncertainty about whether a particular illness may be related to HIV, treatments or other factors,
we offered participants the opportunity to record these conditions within the categories of AIDS defining illnesses
(ADI), HIV-related illnesses, major health conditions other than HIV/AIDS and mental health conditions. We asked
respondents to indicate whether they had experienced conditions in these categories and to specify the condition
and the year in which it was diagnosed. Some recoding was undertaken, for example for a condition that did not
meet the criteria for ADI and the data were transferred to either HIV related conditions or other health conditions.
Regardless of the uncertainty about the aetiology of these conditions among PLWHA (and indeed physicians) we
can see that there is a considerable burden of illness that goes beyond HIV infection for a significant proportion of
the survey respondents. 
Participants were also asked to select from a list of 10 HIV-related illnesses those that they had experienced in the
12 months prior to survey. This section will also cover co-infection with hepatitides, attitudes towards body changes
and health maintenance activities. 
AIDS Defining Illnesses
AIDS is a notifiable condition in New Zealand. According to Ministry of Health guidelines: “[A]n AIDS defining event
determines when a person should be notified to the local Medical Officer of Health. A positive HIV test result is not
notifiable. Once the diagnosis of AIDS has been established, there is a statutory duty to notify the case to the
Medical Officer of Health using the recommended notification form and special code” (Ministry of Health 2004).  
The case definition for AIDS requires both laboratory evidence of HIV infection and clinical confirmation of one of
25 specific conditions (Ministry of Health 2004). These conditions are therefore known as AIDS defining illnesses.
The category system for defining the stages of HIV disease progression was in large part based on an
understanding of the progress of the disease as degenerative with little backwards movement through the
categories. There are now numerous HIV positive people who have at some time experienced an AIDS defining
illness but would now be classed at a less severe stage of disease progression. 
Around one in five respondents (21.6%) said they had been diagnosed with an AIDS defining illness at some point.
The most common illnesses listed by respondents in this category were Pneumocystis Pneumonia and Kaposi’s
Sarcoma. 
HIV/AIDS Related Conditions
One-quarter of respondents (24.9%) indicated that they had experienced an HIV-related illness at some point.
Within this group the most common conditions mentioned were skin problems (such as rashes), shingles and
candida /thrush.
In a separate question, participants were asked to select from a list of 10 conditions commonly associated with HIV
infection those that they had experienced in the 12 months prior to survey. In order to gain a clearer picture of
respondents’ burden of illness, this list was expanded from the previous HIV Futures New Zealand survey to include
six additional conditions.
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TABLE 9 Health conditions experienced in the past 12 months
Condition Percent
Low energy/fatigue 80.9
Diarrhoea 69.3
Sleep disorder 64.2
Weight loss/underweight 40.0
Confusion/memory loss 43.7
Nausea or vomiting 38.9
Lipodystrophy/lipoatrophy 34.7
Raised cholesterol/triglycerides 33.1
Peripheral neuropathy 16.8
Insulin resistance 4.4
AIDS neurological syndrome 1.5
Those reporting weight loss were significantly more likely to have a body mass index (BMI) in the underweight (18.5)
or normal (18.5-25) categories (63.6% v 42.7%,x2(6, N=184) = 13.38, p<0.01) (everybody.co.nz, 20071). 
Attitudes towards body image
Lipodystrophy and lipoatrophy have created additional difficulties for positive people (see for example Persson
2003). While there is still some debate over the most appropriate clinical case definition for these conditions, self-
reported body changes remain an important component of diagnosis (Carr et al 1999, Behrens et al 2000). To
assess the impact of these we asked participants to respond to a series of statements about their body image.
These are presented in Table 10 for both the total sample, and for those who indicated that they had experienced
lipodystrophy or lipoatrophy in the past 12 months. As can be seen, over half of the sample (58.7%) disagreed with
the statement Body changes due to lipodystrophy make it obvious to others that people have HIV, while just over
half of the sample agreed with the other two items. The responses of those with lipodystrophy/lipoatrophy were
more likely to be suggestive of a poorer body image.
TABLE 10 Attitudes around body image 
(percentages of total sample, those with and without lipodystrophy)
Other Health Conditions
29.8% respondents indicated that they had been diagnosed with a major health condition other than HIV/AIDS. The
most common conditions listed under this heading were cardiovascular disease (e.g. high blood pressure),
hepatitis C, asthma and diabetes. 
1 Note that BMI in New Zealand differs slightly for people of Maori and Pacific Island background. There is no difference in the classification
of ‘underweight (BMI< 18.5) and only slight differences for the other categories. 
% of total sample % of those with
lipodystrophy
% of those without
lipodystrophy
Changes in my body
due to HIV / AIDS have
made me feel sexually
unattractive.
strongly disagree
disagree
agree
strongly agree
10.6
35.2
35.9
18.3
2.0
28.0
38.0
32.0
15.2
39.1
34.8
10.9
I am happy with the
way my body looks.
strongly disagree
disagree
agree
strongly agree
9.3
34.3
47.1
9.3
18.4
51.0
28.6
2.0
4.4
25.3
57.1
13.2
Body changes due to
lipodystrophy make it
obvious to others that
people have HIV
strongly disagree
disagree
agree
strongly agree
15.8
42.9
30.8
10.5
4.3
26.1
50.0
19.6
21.8
51.7
20.7
5.7
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Viral Hepatitis
Hepatitis is a term that refers to inflammation of the liver. Six different types of viral hepatitis have been identified so
far. Hepatitis A, B and C are more commonly known in New Zealand but hepatitis D, E and G have also been
identified. For HIV positive people, co-infection with hepatitis may affect both people’s health and/or their decisions
in relation to antiretroviral treatments (Mijch 2003). 
Vaccination is available for hepatitis A and B, but not for hepatitis C. Hepatitis B vaccination is available free of
charge in New Zealand for children under 16 years old, household and sexual contacts of known carriers and for
participants in a nationwide screening program (Ministry of Health)
We asked about diagnosis of, and vaccination against, hepatitis A and B, and some more detailed questions about
diagnosis and experience of hepatitis C.
Hepatitis A
Over one quarter of the participants (11.1%) had at some point had hepatitis A, and 54.3% had been vaccinated
against this virus. This means that 34.6% of the respondents may currently be at risk of hepatitis A infection.
Population data indicates that the incidence rate of hepatitis A was 2.9 per 100,000 (122 cases, 0.003%) (Population
and Environmental Health Group, 2007) 
Hepatitis B
A total of 13.8% of respondents had at some time been diagnosed with hepatitis B. Of these, 60.9% had cleared
the infection, 26.1% (n=6) had an ongoing infection and one person had a chronic infection. The majority of those
who had been diagnosed with hepatitis B said they did not experience any symptoms related to hepatitis B (80.6%). 
In addition to those who had experienced hepatitis B infection, 57.4% had been vaccinated against this virus. This
means that 28.8% may currently be at risk of being infected with hepatitis B. Population data indicates that the
incidence rate of hepatitis B was 1.5 per 100,000 (0.002%) (Population and Environmental Health Group, 2007). 
Hepatitis C
Almost half (46.9%) of respondents had not been tested for hepatitis C, slightly lower than the figure reported in the
first HIV Futures New Zealand survey (53.8%). In the previous survey we used a series of items including test results,
year of diagnosis with hepatitis C, and designation of hepatitis C as a major health condition to determine the
percentage of respondents with hepatitis C. In HIV Futures New Zealand 2, we also asked respondents if they had
ever had hepatitis C, and 7.7% (N=15) said that they had. 
Population data indicates that the incident rate of hepatitis C was 0.8 per 100,000 (34 cases in 2006, 0.001%)
(Population and Environmental Health Group, 2007). 
Mental Health
Issues around mental health continue to figure large in discussions of the needs and status of positive people in many
parts of the world. While a survey like this cannot expect to offer a clinical perspective on mental health status, we can
give an overview of some of the experiences of positive people that fall within the broad area of mental well-being.
Psychiatric Medications
In the six months prior to completing the survey, 18.6% of PLWHA said they had taken medicines prescribed for
depression. Population data suggests that this is higher than the New Zealand average. At a population level 5.9%
had been prescribed an anti-depressant (Ministry of Health, 2007) in the previous year. 
Just over one-fifth of respondents (22.9%) reported having taken medicines prescribed for anxiety in the past 6
months. In addition 2.9% of the sample indicated that they had taken anti-psychotic medication. 
Diagnosis of a Mental Health Condition
We asked respondents if they had been diagnosed with a mental health condition and 28.8% reported that they had
had such a diagnosis. Of those reporting a diagnosis, the vast majority had been diagnosed with depression (25.1% of
the total sample). 28.5% of people had received this diagnosis in the past 2 years. The next most common condition
was anxiety, reported by 14.1% of the total sample. 40.7% of those reported having received this diagnosis over the past
2 years. The New Zealand Mental Health Survey (Oakley Browne et al 2006) gives some comparative data for the New
Zealand population. In this survey, 14.8% reported diagnosis with any anxiety disorder in the previous 12 months, with
2.0% specifically reporting a generalised anxiety disorder. Lifetime diagnosis with any anxiety disorder was 24.9%. The
survey reports 8.0% diagnosis with any mood disorder in the 12 months prior to survey and 5.7% with a major
depressive disorder. Lifetime diagnosis was 20.2% with any mood disorder and 16.0% with a major depressive disorder. 
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Symptoms of Depression
We included a set of four items modified from those in the Beck Depression Inventory (BDI), a widely used
depression assessment instrument. These were: (1) I cry or feel like crying all the time; (2) I don’t enjoy things the
way I used to; (3) I have lost interest in other people; and (4) I don’t feel it’s worth going on. It was not our intention
to compare PLWHA to the community norms for depression provided by the BDI - this would have required
inclusion of the full sixteen item scale. However, these four items do provide an indication of some of the major
symptoms associated with depression. These are also items that are often used in general practice as reasonable
indicators for the prescription of anti-depressants. 
As can be seen in Table 11, a considerable proportion of PLWHA agreed or strongly agreed with each of the items.
The strongest level of agreement was with item 2 (not enjoying life as much), followed by 3 (losing interest in others).
Over one fifth of the respondents (22.3%) agreed or strongly agreed with item 1 (crying all the time), and 15.7%
agreed or strongly agreed with item 4 (not worth going on). We can look at the number of these items that people
agreed with as a way of measuring the extent of depressive symptoms. Overall, 53.0% agreed or strongly agreed
with none of these items, 16.0% with one item, 15.3% with two items, 7.1% with three items, and 8.1% of the sample
agreed with all four items. Agreement with all four items may be suggestive of clinical depression. 
TABLE 11 BDI depression symptom items: percentage of total sample
Strongly agree Agree Disagree Strongly disagree
I cry or feel like crying all the time 2.4 15.9 49.3 32.4
I don’t enjoy things the way I used to 10.7 35.4 35.9 18.0
I have lost interest in other people 5.7 21.3 46.9 26.1
I don’t feel it’s worth going on 5.2 10.5 35.7 48.6
HEALTH MAINTENANCE
We asked participants about a range of activities that they may engage in to improve their health. The results are
shown in Table 12 below. The most common health-enhancement activity was eating healthily, followed by sleep,
exercise, and relaxation. Those with better self rated health were significantly more likely to indicate that they
engaged in exercise, spending time with friends and spending time with their partner. Those with better well being
were significantly more likely to indicate that they engaged in healthy eating, spending time with friends, relaxation,
spending time with their partner and spending time with family.
TABLE 12 Health improvement strategies
Healthy eating 78.6
Sleep 74.9
Exercise 69.8
Relaxation 65.1
Spending time with friends 54.4
Spending time with family 36.3
Spending time with partner 35.3
Spending time with pets 35.3
(Multiple responses possible)
Attitudes to Health Management
Participants responded to a number of statements about health management in relation to health improvement
strategies, antiretroviral therapies and complementary therapies. The items on antiretroviral and complementary
therapies are presented in the relevant sections of the report. When asked about health management strategies,
almost all participants agreed that exercise, healthy eating and an optimistic outlook were important or very
important strategies (see Table 13). Those who indicated that they exercised and ate well were more likely to agree
with the respective statements.
TABLE 13 Attitudes to health management: percentage of total sample
Prophylaxis
10.0% of respondents were taking prophylaxis for opportunistic infections, while 7.0% said they did not know. Those
using prophylaxis were more likely to have experienced an AIDS defining illness, to have a lower CD4 count and to
have been HIV positive longer.
Other Health Monitoring
We asked a series of questions about other health monitoring activities. 15.5% had taken a bone density test in the
last two years and 8.5% had taken a test more than two years ago. 42.0% had taken a fasting cholesterol test in
the last two years and 13.0% had taken one more than two years ago. The long term effects of living with HIV and
medication have made health concerns such as high cholesterol, cardiovascular difficulties and osteoporosis
increasingly important for positive people.
All female respondents who answered this question had undergone a cervical smear (Pap) test (100.0%) and 66.6%
said they had taken one in the last twelve months. On average women had undergone one test in the previous year.
The CDC recommends that all HIV-positive women have a pap smear test every year. This means that up to one-
third of women who should have had an annual pap smear had not, although it may be possible that some of these
women did not require one. On their most recent test, most women (82.1%) reported that the result was ‘normal’,
while five women reported atypia. 
Other Medication
Participants used a range of other prescribed medication. In all 46.3% of respondents were using other type of prescribed
medication other than antiretroviral therapies. A high proportion of participants reported using antidepressants and other
medicines for mental health conditions. Please refer to pg 7 for discussion of these medicines.
COMPLEMENTARY THERAPIES
We asked participants if they had used any complementary therapies in the previous six months, including
therapeutic use of marijuana, and to indicate the types of therapies used and where these products or services were
obtained. In order to gain an overall picture of the use of these modalities, the question asked participants to
indicate all complementary therapies they had used, not only those used for HIV/AIDS. Over three-quarters of
respondents (66.5%) indicated that they had used some kind of complementary medicine or therapy in the previous
six months. Almost half of the sample (47.0%) had taken vitamin or mineral supplements. Almost one-third (31.2%)
of respondents had used massage, while 14.4% had used meditation. 17.7% of respondents indicated that they
had used marijuana for therapeutic purposes.
TABLE 14 Use of complementary therapies in the past six months
Vitamin / mineral supplements 47.0
Massage 31.2
Marijuana for therapeutic purposes 17.7
Meditation / visualisation 14.4
Herbal therapies / supplements 14.0
Acupuncture 2.8
Traditional Chinese medicine 3.3
Other traditional medicine -
Other complementary therapy 0.5
(Multiple responses possible)
Participants were asked where they obtained these services or supplements. While one in six obtained these from a
private practice, a similar proportion obtained them either from an AIDS community organisation or a PLWHA group.
Those that selected the ‘other’ option mostly obtained these medicines from health food shops or similar establishments.
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Looking after my physical fitness is an
important part of managing my HIV
infection
strongly agree
agree
disagree
strongly disagree
52.1
43.2
4.2
0.5
Healthy eating is an important part of
managing my HIV infection
strongly agree
agree
disagree
strongly disagree
43.9
50.0
4.7
1.4
Keeping an optimistic frame of mind
is an important part of managing HIV
infection
strongly agree
agree
disagree
strongly disagree
54.5
42.2
2.4
0.9
TABLE 15 Source of complementary therapies
Health Food Shop 34.8
Private practice 37.0
AIDS Foundation Centre 9.6
Health Service 9.6
PLWHA organisation 11.9
Friends/family 5.2
Pharmacy/supermarket 3.7
Other 14.8
(Multiple responses possible)
Almost three-quarters of respondents (71.5%) agreed that complementary therapies can improve well-being, while
60.1% agreed that complementary therapies can boost the immune system. Almost half of respondents agreed that
complementary therapies can reduce side effects (48.0%) and  delay the onset of illness due to HIV (47.1%) (see Table
16. below). However, over one third of respondents were unsure about these statements and these people were
significantly more likely not to have used complementary therapies. Roughly equal proportions of respondents agreed
and disagreed with the statements on whether there is sufficient evidence about the benefits of complementary
therapies, whether medicine’s focus on anti-HIV drugs was limited and whether complementary therapies constituted
a central part of their anti-HIV treatments. Again, there was considerable uncertainty about these issues. 
TABLE 16 Attitudes to complementary therapies: percentage of total sample
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Complementary therapies can delay
the onset of illness due to HIV
strongly disagree 
disagree
agree
strongly agree
don’t know
1.9
9.7
29.1
18.0
41.3
Complementary therapies can
improve well-being
strongly disagree 
disagree
agree
strongly agree
don’t know
1.0
1.4
38.2
33.3
26.1
Complementary therapies can reduce
the side effects of conventional
medical treatments
strongly disagree 
disagree
agree
strongly agree
don’t know
2.0
7.4
29.9
18.1
42.6
There is not enough evidence to be
sure about the benefits of
complementary therapies
strongly disagree 
disagree
agree
strongly agree
don’t know
7.0
25.9
30.3
7.5
29.4
Medicine’s focus on anti-HIV drugs is
very limited
strongly disagree 
disagree
agree
strongly agree
don’t know
3.9
26.6
25.1
12.8
31.5
Complementary therapies can boost
the immune system
strongly disagree 
disagree
agree
strongly agree
don’t know
1.5
3.9
37.4
22.7
34.5
Complementary therapies are a
central part of my anti-HIV treatments
strongly disagree
disagree
agree
strongly agree
don’t know
9.6
27.8
19.7
11.6
31.3
TREATMENTS
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This chapter reports on the treatment experiences of PLWHA. The main emphasis is on antiretroviral
treatments, as these are dominant in the lives of HIV positive people. There is also some discussion of
medicines taken for other health conditions. While we have seen a reduction in the number of medicines
taken and the frequency of taking them over the past few years (see for example Fogarty et al 2003), the
burden of medicine (largely pill based) remains high. 
ANTIRETROVIRAL THERAPY
Highly active antiretroviral therapy remains the single factor that has most altered the clinical outcomes for people
living with HIV. The introduction of ARV has reshaped the HIV epidemic in developed countries, and is increasingly
doing so in developing nations and resource poor settings. The years in which these treatments have been
available have seen improvements in the efficacy and tolerability of treatments, but this period has also shown us
that they are clinically and pharmacologically complex. In the following section we examine some of these
consequences from the perspective of PLWHA, but we also examine the psychological and social impacts of the
treatments. 
Of the full sample, 79.0% had used ARV at some point, and 72.9% were currently using these treatments. If we look
at the gender breakdown of ARV use, we observe that 60.0% (n=18) of women compared with 74.6% (n=135) of men
were currently using ARV. A summary diagram of the uptake of antiretrovirals can be found in Figure 3 on page 12.
FIGURE 3 Use of Antiretroviral Therapy
(Note: Ns and percentages may be reduced due to missing data)
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Full Sample  
N=215
Have used continuously 
67.4% (N=104)
of those currently using 
(48.4% of total sample)
Have stopped at some  
point in the past 
32.9% (N=51)
of those currently using 
(23.7% of total sample)
Have used before,  
but not currently 
22.4% (N=13)
of those currently not using 
(6.0% of total sample)
Have never used 
77.6% (N=45)
of those currently not using 
(20.9% of total sample)
Currently using  ARV   
N=156  72.9%
Not using  ARV   
N=58  27.1%
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Those Currently Using ARV (mono-therapy and combination therapy) 
The majority of participants (73.6%) were on a combination of 3 antiretroviral drugs2, with 23.7% on more than three
antiretroviral drugs and four people (2.7%) on two.
TABLE 17 Antiretroviral drugs used by respondents: percentage of those currently using ARV
Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Lamivudine (3TC, Epivir) 17.2
Abacavir (Ziagen) 14.9
Stavudine, d4T (Zerit) 4.7
Zidovudine, AZT (Retrovir) 4.7
Didanosine, ddI (Videx) 4.7
ddI ec (Videx ec, didanosine ec) 1.4
Zalcitabine, ddC (Hivid) -
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Nevirapine (Viramune) 9.8
Efavirenz (Sustiva, Stocrin) 37.2
Delavirdine (Rescriptor) -
Nucleotide Analog Reverse Transcriptase Inhibitors (NtARTIs)
Tenofovir (Viread) 4.7
Protease Inhibitors
Ritonavir (Norvir) 4.7
Atazanavir (Reyataz) 5.6
Saquinavir (Invirase, Fortovase) -
Nelfinavir (Viracept) 2.3
Indinavir (Crixivan) 3.7
Tipranavir -
Fusion Inhibitor 
T-20 0.5
Combination Medications
Kaletra (lopinavir and ritonavir) 9.8
Combivir (AZT & 3TC) 40.9
Trizivir (AZT & 3TC & Abacavir) 1.4
Other 3.3
Respondents were also asked specifically about their use of the immune stimulant Interleukin 2 and no respondents
were using it.
Difficulties of Taking ARV
Overall, 44.3% of those currently using antiretroviral treatments reported that they had some difficulty taking them
(Table 18). Of those currently using antiretroviral treatments, 23.6% indicated they had difficulty remembering to take
the drugs on time, 16.6% said they had difficulty transporting medication, 15.9% taking a large number of tablets
and 12.7% taking medication in public. 
2 Combivir counts as 2 drugs, Trizivir as 3 drugs, Kaletra as 2 drugs, Kivexa as 2 drugs
TABLE 18 Difficulties of taking ARV among those currently using ARV
Side effects 26.1
Remembering to take drugs on time 23.6
Carrying/transporting medication 16.6
Taking a large number of tablets 15.9
Taking medication in public 12.7
Organising meals around medication 8.3
ARV drugs make it difficult to take medication for other health conditions 3.2
Medication taken for other health conditions makes it difficult to take ARV 0.6
Other 2.5
(Multiple responses possible)
Side effects were reported by 26.1% of respondents currently using ARV. The most commonly reported problems
were diarrhoea, nausea or vomiting and sleep disturbances. 
Attitudes to ARV
Most respondents reported concern over the future efficacy of their treatments. Over half (58.1%) agreed or strongly
agreed with the statement I am worried that in the future my medication will stop working for me. When asked to
respond to the statement Taking tablets gives me an unwanted reminder that I have HIV, 53.6% indicated agreement
and 45.1% indicated disagreement.
TABLE 19 Attitudes to medication: percentage of those currently using ARV
strongly disagree disagree agree strongly agree don’t know
I am worried that in the 8.5 21.6 43.1 15.0 11.8
future my medication 
will stop working for me
Taking tablets gives me 14.4 30.7 38.6 15.0 1.3
an unwanted reminder 
that I have HIV
Health Status of Those Using ARV
The mean viral load level among respondents who were taking ARV (2738 copies/ml) was significantly lower than
for those who had taken ARV in the past (1,257,055 copies/ml), or those who had never taken ARV (27520
copies/ml), F(2)= 10.555 p <0.001). This difference is mainly explained by the large proportion of those on ARV with
a viral load below detectable levels as can be seen in Table 20.
TABLE 20 Viral load of those taking and not taking antiretroviral therapy (percentage within rows)
VIRAL LOAD ON MOST RECENT TEST   
Below 500-9999 10000-49999 50000+
detectable 
levels 
ARV Use Current 95.1 2.1 0.7 2.1
Past 63.6 9.1 18.2 9.1
Never 47.1 17.6 26.5 8.8
x 2(6)= 55.865 p<0.001
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The mean CD4 count among those who were taking ARV was higher than for those who had taken ARV previously
(mean of 502 cells/µl compared to 440 cells/µl), and similar to those who had never taken ARV (mean of 507
cells/µl). This difference was not statistically significant F(2)= 0.353, p= 0.703. 
TABLE 21 CD4 of those taking and not taking antiretroviral therapy (percentage within rows)
CD4 ON MOST RECENT TEST
0-249 250-499 500+
ARV Use Current 12.7 46.0 41.3
Past 32.5 45.5 36.4
Never 10.0 32.5 57.5
x 2(4)= 3.774 p=0.437
Those currently taking antiretroviral treatments were more likely to have had an AIDS defining illness (27.5%
compared to 15.4% among those currently not taking antiretrovirals and 2.2% among those who have never taken
ARV). The average length of HIV diagnosis was 10.6 years for those taking ARV, compared with 13.2 for those who
had taken ARV in the past and 3.3 years for those who have never taken ARV. 
When asked to rate the effect of commencing ARV on their physical health, 60.0% said that their health improved,
23.3% said it had fluctuated, 13.3% said it had stayed the same and 3.3% said it had deteriorated. When asked
about the impact of ARV on their overall feeling of well-being, 49.7% said it had improved, 28.2% said it had
fluctuated, 18.8% said it had stayed the same and 3.4% said it had deteriorated.
FIGURE 4 Effect of commencing antiretroviral medication on health and well being 
(percentage of those taking ARV)
THOSE ON COMBINATION THERAPY
There was considerable variation in the combinations currently in use by respondents. The most common
combination was 2 NRTI-1 NNRTI (54.1% of those on ARV, N=79), followed by 2 NRTI-2 PI (10.3%, N=15), 2 NRTI-
1 PI (8.2% N=12), 3 NRTI (6.2% N=9)3. 
On average, respondents had started using combination therapy 5.9 years ago (minimum=1 month,
maximum=20.0 years, median=5.5 years). Most started combination therapy at a time when their viral load was high
(median= 55,000, mean = 119,576 copies/ml) and their CD4 count was low (median=190, mean = 214). Table 22
below, gives the CD4 and viral load of respondents at the time they commenced combination antiretroviral treatment. 
TABLE 22 Results of serological tests prior to commencement of ARV: percentage of those on ARV
HIV VIRAL LOAD
Below 500-9999 10000-49999 50000+ Total
detectable 
levels
Cd4/ 500+ 3.6 3.6 1.8 0 8.9
T-cell 250-499 7.1 0 7.1 17.9 32.1
count 0-249 10.7 5.4 7.1 35.7 58.9
Total 21.4 8.9 16.1 53.6 100.0
Deteriorated
P
Fluctuated
Improved
Stayed the same
Health
Well being
0 10 20 30 40 50 60
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When asked about the circumstances surrounding their commencement of combination therapy, respondents were
most likely to indicate that they were advised to do so by their doctor (73.5%), although the importance of clinical
indicators, treatment developments and treatment information is also clear.
TABLE 23 Circumstances surrounding commencement of combination therapy treatment among all
those currently on combination ARV
My doctor advised me to begin this treatment 64.3
I had a big drop in my CD4/T-cell count 38.2
I became very ill 30.6
I had a big rise in my viral load 27.4
I had just tested positive to HIV 21.7
New drugs became available 14.0
I was hospitalised due to HIV-related infections 17.2
Information showed that this treatment is effective 12.1
A treatments officer advised me to begin this treatment 5.7
Close friends advised me to begin this treatment 5.1
A number of my positive friends started this treatment 3.2
My partner advised me to begin this treatment 1.3
Other 5.1
(Multiple responses possible) - 
FIGURE 5 Circumstances surrounding commencement of combination therapy treatment among all
those currently on combination ARV
3 NRTI= Nucleoside Reverse Transcriptase Inhibitors, NNRTI= Non- Nucleoside Reverse Transcriptase Inhibitors, NtARTI= Nucleotide
Analog Reverse Transcriptase Inhibitors, PI=Protease Inhibitor
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Different Combinations 
Among those currently using combination therapy, respondents had used between one and eight combinations,
with the median being two. Within the last 12 months, 60.8% had used one combination and 23.8% had used two.
Respondents currently on combination ARV were asked to describe the circumstances surrounding their most
recent change in combination. For a large proportion of PLWHA (42.5%) the side effects had become too severe.
Drugs not working (14.9%) and drug resistance (13.8%) were the next most common responses. 
TABLE 24 Primary circumstance surrounding most recent change in combination among those
currently on combination ARV who have changed combinations
Side effects became too severe 42.5
Drug resistance developed 13.8
They were not working for me 14.9
Taking drugs at the right time was too difficult 5.7
It didn’t fit my lifestyle 3.4
The financial burden became too heavy -
Other (please specify) 19.5
When asked how many combinations they believed they still had access to, 3.6% indicated that they thought they
had only one remaining. 23.2% had a few and 26.8% felt they had many. 44.9% said they didn’t know how many
combinations they had left. Two respondents currently on combination therapy believed they had no combinations
remaining. 
THOSE NOT CURRENTLY TAKING ARV
Of the 27.1% of the sample who were not using any antiretroviral medication, only 22.4% had done so in the past
(n=13, or 6.0% of the total sample). The mean length of time these respondents had been using ARV was 5.2 years
(range 3 months to 18 years) and on average they had ceased using ARV three years prior to completing the survey
(range 1 month to 11.3 years). At the time that they stopped using ARV, one-third were using a combination of three
drugs (33.3%), one-third were using two drugs (33.3%), one-quarter were using four drugs (25.0%), and 8.3% were
on mono-therapy. Of these respondents, 9 (81.8%) said they would consider using antiretroviral drugs in the future. 
Difficulties of Taking ARV
Almost all of those who had taken ARV in the past reported having experienced difficulties taking these drugs
(84.6%). There is some variation in the difficulties experienced by this group and those currently taking ARV (see
Table 25). Overall, a higher proportion of those who had stopped taking antiretroviral drugs nominated difficulties,
particularly difficulties with side effects. However as the number of respondents in this group is very small, the
numbers as well as percentages have been provided in the table below. 
TABLE 25 Difficulties of taking ARV among those who have stopped ARV treatment
% (n)
Side effects 57.1 (8)
Remembering to take drugs on time 35.7 (5)
Taking medication in public 35.7 (5)
Organising meals around medication 28.6 (4)
Carrying/transporting medication 21.4 (3)
Taking a large number of tablets 14.3 (2)
ARV drugs make it difficult to take medication for other health conditions -
Medication taken for other health conditions makes it difficult to take ARV -
Other 7.1 (1)
(Multiple responses possible)
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Health Status of Those Not Using ARV
Those not currently using ARV were asked to describe changes in their health when they had used ARV in the past.
One person (8.3%) said that it had deteriorated, three (25.0%) that it had fluctuated, one (8.3%) that it had stayed
the same, and over half (n=7, 58.3%) said that their health had improved. When asked about the impact of ARV on
their overall feeling of well-being, three people (23.1%) said it had improved, six (46.2%) that it had fluctuated, two
(15.4) that it had stayed the same and two (15.4%) said their well-being had deteriorated. 
Respondents were asked whether they had lifestyle or clinical reasons for ceasing their use of antiretroviral therapy.
Five respondents (41.7%) gave lifestyle reasons for stopping treatment. The most commonly cited reasons were
difficulty taking drugs at the right time (n=3), to clean out the system (n=2) and because taking treatments didn’t
fit their lifestyle (n=2). 
Eleven respondents (84.6%) gave clinical reasons for ceasing ARV treatment. Four respondents said that this was
a treatment break, four said that the cessation was recommended by a health professional other than their doctor
and two that they had stopped due to liver toxicity.
THOSE WHO HAVE NEVER USED ANTIRETROVIRAL DRUGS
20.9% (N=45) of the respondents had never used antiretroviral treatments. Of these 87.8% said they would
consider using antiretroviral drugs in the future. 
When asked what circumstances would lead to their commencing ARV, the principal reasons were clinical (see
Table 26).
TABLE 26 Circumstances that would lead to the commencement of antiretroviral therapy among those
who have never used or previously used antiretroviral drugs
Never used N(%) Previously used N(%)
If I had a significant drop in CD4 / T-cell count 34 (75.6) 7 (53.8)
If my doctor advised me to begin this treatment 30 (66.7) 8 (61.5)
If I became very ill 29 (64.4) 7 (53.8)
If I was hospitalised due to HIV-related infections 25 (55.6) 7 (53.8)
If I had a significant rise in my viral load 20 (44.4) 4 (30.8)
If information showed that combination therapy is effective 16 (35.6) -
If a treatments officer advised me to begin this treatment 13 (28.9) 2 (15.4)
If new drugs became available 7 (15.6) 3 (23.1)
If my partner advised me to begin this treatment 6 (13.3) -
Other 2 (4.4) 2 (15.4)
If close friends advised me to begin this treatment 2 (4.4) 2 (15.4)
When my break from treatment is finished 2 (4.4) 3 (23.1)
If a number of my positive friends began to take up combination therapy 1 (2.2) -
(Multiple responses possible)
ATTITUDES TO ANTIRETROVIRAL THERAPY
Antiretroviral treatments have an impact on many parts of people’s lives, not just on their physical health. As in
previous surveys, we asked respondents to respond to a series of statements about treatments. These fall into three
broad areas: decision making around treatments, relationship with their doctor, and optimism about treatments.
These findings can be seen in Table 27 on page 19.
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TABLE 27 Attitudes to antiretroviral drugs: percentage of total sample
Strongly disagree Disagree Agree Strongly agree Don’t know
I am healthy now and 42.3 29.1 14.1 11.3 3.3
don’t need to use combination 
antiretroviral drugs
People with HIV should start 12.3 31.6 18.4 13.2 24.5
using antiretroviral drugs as 
soon as possible
My doctor and I work together 4.3 5.7 50.2 36.8 2.9
to find the best treatment for me
My doctor knows a lot more 5.6 10.7 42.5 36.9 4.2
about the treatment of HIV than I do.
Combination antiretroviral 41.3 33.3 1.4 4.2 19.7
drugs are ineffective
Combination antiretroviral 20.3 25.5 22.2 3.8 28.3
drugs are harmful
The side-effects of antiretroviral 15.6 42.0 11.3 8.5 22.6
drugs outweigh the benefits
New treatments will be 1.4 2.4 44.3 21.2 30.7
developed in time for me to g
ain benefits
HIV treatments will stop me 3.3 15.2 30.3 21.8 29.4
dying from AIDS
Combination antiretroviral 5.3 8.7 30.9 34.3 20.8
drugs have allowed me to plan 
my life with confidence for the 
long-term
Treatment Decision Making
Most respondents indicated that they disagreed with the statement I am healthy now and don’t need to use
antiretroviral drugs (71.4%). Those who agreed with this statement were more likely to be those not currently using
any antiretroviral drugs. Respondents were more likely to disagree than agree with the statement People with HIV
should start using antiretroviral drugs as soon as possible, although one in four respondents that indicated that they
were unsure about this. Those that agreed with this statement were more likely to be using antiretroviral
medications.
Relationship with Doctor
As with previous surveys, most respondents (87.0%) agreed with the statement My doctor and I work together to
find the best treatment for me, with few expressing uncertainty. Most respondents (79.4%) also agreed with the
statement My doctor knows more about the treatment of HIV than I do. 
Treatment Optimism
Optimism about the value and effectiveness of antiretroviral treatments continues to characterise the treatment
experience, but tempered as always with concerns about the impact and long term effectiveness of these
treatments. Only 5.6% of respondents agreed with the statement Combination antiretroviral drugs are ineffective.
This belief in effectiveness is tempered by an awareness of the potential harm of these therapies as evidenced by
the agreement with the statement that Combination drugs are harmful (22.2% agree, 3.8% strongly agree). This
harm may in part be that experienced as side effects. Around one in five (19.8%) respondents agreed or strongly
agreed with the statement The side effects of antiretroviral drugs outweigh the benefits, while 22.6% were unsure.
There was considerable uncertainty about the long term benefit of treatment. 30.7% of respondents said they were
unsure when asked to respond to the statement New treatments will be developed in time for me to gain benefits,
with most of the remainder agreeing. Similarly, 29.4% were uncertain when asked if HIV treatments will stop me dying
from AIDS, while around half of respondents agreed with this statement (52.1%). Almost two thirds (65.2%) agreed
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with the statement Combination antiretroviral drugs have allowed me to plan my life with confidence in the long term,
while 20.8% were uncertain.
In addition to these items, respondents were asked to indicate how much they and their friends agree with the
statement Antiretroviral drugs mean better prospects for most people. Most (75.7%) agreed with the statement, and
believed their friends would agree with it (60.3%). 
FIGURE 6 Respondents’ and respondents’ social networks’ response to the statement Antiretroviral
drugs mean better prospects for most people
TREATMENT BREAKS
Treatment breaks may take a number of forms and be undertaken for a range of reasons (Grierson, Misson and
Pitts 2004). While there is considerable discussion in the medical community about the potential benefits and
dangers of treatment interruptions, our main emphasis is on the motivations, experiences and consequences of
breaks for HIV positive people. To understand the experience of breaks, we asked respondents to give us some
detailed information about their most recent break.
In all, 32.5% of those respondents currently using antiretroviral medication had taken a break from these at some point.
Most Recent Treatment Break
The date of the commencement of most recent treatment break was provided by 84% of those that had ever taken
a break. Of these 35.7% had taken their most recent break in the two years prior to survey and 21.4% in the previous
one year. Twenty respondents provided information about the length of their treatment break. For these
respondents, the mean length of break was 3.7 months with a median of one month. Of those ever taking a break,
21.7% described it as a structured treatment interruption, while 56.5% described it as a treatment break. Of those
taking a break in the previous two years, four described it as a structured treatment interruption, while seven
described it as a treatment break. 
We asked participants to describe the reasons for taking the break within two major categories: lifestyle reasons,
and clinical reasons. A discussion of the differences between those taking breaks for primarily lifestyle and primarily
clinical reasons can be found in our article on this topic (Grierson, Misson and Pitts 2004). Less than half (44.7%,
n=21) indicated that they had lifestyle reasons for taking a break. The specific reasons are given in Table 28  below.
The most common reason given was travel (n=11), followed by to clean out the system (n=7).
TABLE 28 Lifestyle reasons for taking breaks (number of those taking breaks)
Total taking breaks
Clean out my system 7
Travel 11
Taking drugs at the right time was too difficult 3
It didn’t fit my lifestyle 3
The financial burden became too heavy 1
A special event 3
Other 9
(Multiple responses possible)
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When asked if there was a clinical reason for taking the break, 56.3% (n=27) of those that had taken a break
indicated that there was. Table 29 below details the clinical reasons given for breaks. The most commonly cited
reason was that the break was recommended by their doctor, followed by that the side effects of treatment became
too severe (n=16). 
TABLE 29 Clinical reasons for taking breaks (number of those taking breaks)
Total taking breaks
Recommended by my doctor 17
Side effects became too severe 16
Recommended by other health professional 6
Liver toxicity problems 5
Changing regimens 3
Complications with Hep C 3
Taking part in a clinical trial 2
Drug resistance developed 2
Other 4
(Multiple responses possible)
FIGURE 7 Lifestyle and clinical reasons for taking break
We also asked about the involvement of the participant’s doctor in these breaks. Participants were more likely to
have talked to their doctor about the break prior to taking it (65.3%) than they were during the break (52.1%). Almost
all of those who had taken a break had talked to their doctor after taking the break (87.5%). Almost half (45.2%)
talked to their doctor at all three stages of the treatment break. 14.3% spoke to the doctor during and after the
break, but not before, 28.6% spoke to their doctor before and after the break, but not during, and 11.9% only spoke
to their doctor after the break. 
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Timing too difficult
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We were also interested in the outcome of the treatment breaks, both in terms of clinical markers and experience
of health and well-being. Table 30 below gives the results of the four questions asked. Around one third of
respondents said that their health remained stable, while the reminder were spread fairly evenly across the
categories of improved, fluctuated and got worse. When asked about their general well-being, a similar proportion
said that it had remained stable (30.0%). With well-being, there was a more distinct pattern for the remaining
categories with decreasing proportions saying that it had improved, (29.1%) fluctuated (23.9%) or got worse
(17.0%). 
TABLE 30 Effect of break on health and well being (percentage of those taking break)
Health Well being
Stayed the same 38.8 32.7
Improved 20.4 38.8
Fluctuated 18.4 10.2
Deteriorated 22.4 18.4
The impact of these breaks on clinical markers was less positive. The majority of respondents indicated that their
viral load had increased (deteriorated) (71.7%), while 15.2% said that it had stayed the same and 10.9% (n=5) said
that it had decreased (improved). The majority of respondents (60.4%) also indicated that their CD4 count had
decreased (deteriorated) as a result of the break, while 16.7% said that it had stayed the same, 14.6% that it had
increased (improved) and 8.3% (n=4) said that it had fluctuated. 
FIGURE 8 Impact of treatment break on health, well being and clinical markers
ANTIRETROVIRAL RESISTANCE
The development of resistance to antiretroviral treatments is an ever increasing concern for HIV positive people. HIV
can develop resistance to one or more treatments as a result of its continual mutation and this resistance can result
in the failure of treatments (Deeks 2003, Prejdova et al 2004). Resistance can result from a lack of early and
persistent suppression of viral replication, missed doses of antiretroviral medications or infection with a resistant
strain. There are a number of resistance tests available but they generally fall into two categories: genotypic
resistance tests that look for mutations of the virus in its genetic code; and phenotypic resistance tests where the
virus is cultured and the performance of drugs tested directly. We asked respondents whether they had had
resistance tests and what the clinical and treatment outcomes of this were.
22.4% of respondents who had ever used antiretroviral treatments indicated that they had taken a viral resistance
test. This included 22.1% of those who were currently on antiretroviral treatment and 25.0% of those who were not.
The average length of time since the most recent resistance test was 2.3 years (median=1.3 years). 55.8% of
respondents had had their most recent test in the last two years (58.0% of those currently on ARV, 33.3% of those
not). Of those who had resistance testing, 51.4% found resistance to one or more antiretroviral drugs. This resulted
in a change of drugs for all of those (N=19) where resistance was shown. 
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DOSING AND ADHERENCE
Adherence to antiretroviral medication continues to be a significant concern for both PLWHA and physicians
(Gauchet et al 2007, Chesney 2003). The high degree of adherence required for these treatments to be effective
and in order to prevent the development of resistance is far greater than that required (or observed) for other health
conditions. Respondents were asked the number of times they took a range of medications per day. On average,
PLWHA were taking medication 2.3 times a day (range 0 to 6, median=2). The number of times they were taking
specific types of medication is shown in Table 31 below. 53.4% of the sample was taking ARV twice daily, 22.7%
three times a day and 9.7% once a day.
TABLE 31 Number of times participants take medications
Mean Median Range
Antiretroviral drugs 2.0 2.0 0-4
Complementary therapies 0.9 1.0 0-3
Medication for other health conditions 1.4 1 0-5
Participants who were currently using antiretroviral medication were asked how many doses they had missed on
the day prior to completing the survey and the day before that. Combining the data from these two measures,
92.4% reported missing no doses on the two days, 5.1% missed one dose, two people missed two doses and two
people missed four or more doses.
PRESCRIPTIONS
We asked participants who prescribed their antiretroviral medications. In recognition of the multiple prescribing sites
people utilise, respondents were able to nominate more than one source. Over three-quarters (85.4%) of
respondents obtained their prescription from a specialist in an outpatient clinic, while some obtained them from a
doctor at a sexual health centre (5.1%), an HIV specialist while an inpatient (3.8%), another GP (3.8%), or from an
HIV GP (3.2%). 
Participants were most likely to obtain their prescriptions from one place (60.5%) with fewer saying two places
(27.9%), and considerably fewer three or more (8.2%). When asked about the difficulty of obtaining their
prescriptions, over half (68.5%) said it was not difficult, 28.2% that it was somewhat difficult and 3.4% (n=5) that it
was very difficult.
CLINICAL TRIALS
7.1% of all participants (n=15) had participated in a clinical trial for HIV related treatment in the last two years. The
majority of these indicated that they had decided to participate because their experience could benefit others
(n=11), while some said they had made the decision with their doctor (n=8). Two people said they had participated
because they felt they had enough information about the trial and one gave the reason that other treatments were
not working. 
VACCINES
The attempt to develop a therapeutic vaccine for HIV positive people has been a significant part of the
pharmacological research effort in recent years (Steinbrook, 2007, Mwau and McMichael 2003) while the results
have been, as yet, far from promising. Nonetheless, we are interested in monitoring participants’ perspectives on
this issue. We asked respondents to indicate their agreement with the statement I would be willing to participate in
a HIV vaccine trial. Almost one quarter (22.6%) said they did not know, while 55.2% either agreed or strongly agreed
with the statement. A further 13.7% disagreed and 8.5% disagreed strongly. 
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HEALTH SERVICES
Treatment
We asked respondents to identify the physician they see for the clinical management of their HIV and for general
health issues. Generalist GPs were the key physicians for general health management, while HIV GPs and HIV
specialists were the primary providers for a significant proportion of PLWHA. Hospital-based HIV specialists were
the primary providers of HIV specific treatment for a large majority of respondents, while much smaller numbers
nominated other types of doctors (see Table 32). 29.3% of respondents said that the doctor they saw for general
medical services was the same doctor they saw for HIV-related treatment. Of those who saw a different doctor,
99.2% said that that doctor knew their HIV status. 
TABLE 32 Physician used for general and HIV related treatment: percentage of total sample
For general treatment For HIV specific treatment
GP 52.1 3.0
GP with high HIV caseload 20.6 3.6
HIV specialist at outpatient clinic 18.0 80.0
Doctor at sexual health centre 4.1 6.7
HIV specialist at in ward at hospital 3.6 5.5
Other doctor 0.5 0
Other 1.0 1.2
Services Used in the Last 6 Months
We presented respondents with a list of services, both clinical and ancillary and asked which they had used in the
last six months. Clinical services were the most utilised in the list with 79.1% having used an HIV specialist at an
outpatient clinic,  55.8% a GP, 21.9% a dentist and 20.0% an HIV GP. Support services were also used, with 13.5%
reporting having used a hospital social worker or nurse, 12.6% the AIDS Foundation centre and 8.8% support staff
at NZAF (see Figure 9). 
FIGURE 9 Services used in the last six months (percent of total sample)
(Multiple responses possible)
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OTHER SERVICES
Participants were asked whether they were currently using a range of services and, if so whether they used them
through an HIV/AIDS organisation or through another organisation. Treatments advice was the most commonly
used service at HIV/AIDS organisations, with around one-third of respondents selecting this item. HIV/AIDS
organisations were also used for counselling, social contact with other PLWHA and peer support by substantial
numbers of respondents. Other organisations were more likely to be used than HIV/AIDS organisations for
pharmacy services, complementary therapies, financial services, internet access, transport, housing assistance,
mental health services, legal advice and employment services.
TABLE 33 Percent of respondents who use services through HIV/AIDS organisations and other
organisations (percent of total sample)
Use service at Use service at other 
HIV/AIDS organisation organisation
Treatments advice 34.4 17.2
Counselling 30.7 11.6
Social contact with other PLWHA 20.0 3.7
Peer support group 20.0 6.0
Informal peer support 20.0 7.4
Treatments information 14.9 6.0
Pharmacy services 13.0 30.2
Complementary therapies 12.1 20.9
Financial assistance 8.8 14.0
Internet based information 7.9 12.6
Library 7.4 16.3
Community education campaigns 7.0 3.3
Internet access 5.6 17.7
Mental health services 5.1 11.2
Legal advice 4.7 14.4
Housing assistance 4.2 13.0
Respite care 2.8 4.2
Financial advice 2.3 13.5
Transport 2.3 9.3
Volunteer carer 1.9 3.3
Return to work skills 1.4 8.8
Employment services 1.4 9.8
Drug/alcohol treatment 1.4 5.6
Paid carer 0.9 4.2
(Multiple responses possible)
Slightly less than one-fifth (17.6%) of respondents indicated that there were services they felt they needed but did
not have access to. The services most commonly nominated were access to affordable complementary therapies,
financial advice or assistance, peer support and more information about living with HIV. 
INFORMATION
Sources
Respondents were asked to nominate from a list of potential sources, those that were important sources of
information on treatments and HIV management, and living with HIV. This distinction is in part based on our and
others’ qualitative work in this area which suggests that PLWHA make a distinction between HIV as a health
condition and the day to day management of HIV as a social and psychological experience. We have presented
these data in two tables (Table 34 and Table 35) and for each we have reported the percentage of the total sample
that selected each source and the percentages of those in and not in paid employment that selected each source. 
Information about HIV Treatment and Management
HIV specialists at outpatient clinics were considered to be an important source of information on HIV treatment and
management by the majority of respondents (83.3%), while smaller numbers nominated GP’s (27.9%), HIV GP’s
(25.1%) and HIV specialist nurses (24.7%). Importantly information from the community sector figured significantly in
the responses to this item, including HIV/AIDS organisation publications (33.0%) and HIV magazines and newspapers
(28.4%). The internet was an important source of information for just under one-third of respondents (29.8%).
TABLE 34 Sources of information about treatments (percentage of sample)
Source In Paid Not In Paid Total 
Employment Employment Sample
HIV specialist (outpatient) 82.6 84.3 83.3
Publications from HIVAIDS groups 36.4 28.9 33.0
Internet 34.1 22.9 29.8
HIV magazine/newspaper 29.5 25.3 28.4
GP 25.0 31.3 27.9
GP with high HIV caseload 25.0 25.3 25.1
HIV specialist nurse 23.5 25.3 24.7
NZAF staff (treatments-specific) 25.8 16.9 21.9
HIV positive friends 23.5 16.9 20.9
Body Positive staff (treatments-specific) 24.2 15.7 20.9
Body positive staff (others) 22.7 14.5 19.5
HIV specialist (inpatient) 18.2 19.3 19.1
CART 15.2 24.1 19.1
Articles in gay press 18.2 7.2 13.5
NZAF staff (others) 15.2 10.8 13.0
Sexual Health Service 12.9 10.8 12.1
Pharmacist 12.1 12.0 12.1
Dentist 11.4 12.0 12.1
Partner 12.9 8.4 11.2
Publications from other sources 11.4 4.8 8.8
Other doctor 8.3 6.0 7.9
Other HIV/AIDS support organisations 6.8 6.0 6.5
Positive Women 5.3 8.4 6.5
Other friends 6.8 4.8 6.0
Alternative/Complementary therapist 5.3 6.0 5.6
Dietician 5.3 3.6 5.1
Family/Whanau 3.8 6.0 4.7
Other nurse 6.8 1.2 4.7
Refugee Health Education Program 2.3 - 1.4
Family planning association 1.5 1.2 1.4
Haemophilia society 2.3 - 1.4
Injecting drug users organisation 1.5 - 0.9
NZ Prostitutes Collective 0.8 1.2 0.9
(Multiple responses possible)
Differences between participants in and not in paid employment can be seen in a number of the sources listed.
Generally those who were not in paid employment listed fewer sources of information and were less likely to list any
specific source, with the exceptions of medical staff, CART and family. This is particularly noticeable in nominations
of Body Positive staff, NZAF staff and publications. The internet is also nominated by fewer of those not currently in
paid employment, perhaps due to limited access. 
When asked in a separate question to nominate their three most important sources of information about treatments
and health management, 55.5% of respondents nominated a hospital-based HIV specialist. Smaller numbers of
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respondents nominated staff at HIV/AIDS organisations, including Body Positive (9.2%) and New Zealand AIDS
Foundation (NZAF) (5.6%). The responses for the second and third most important information sources were
spread more evenly throughout the range of possible sources. Similar numbers of respondents nominated their GP
(16.9%) or HIV specialist (16.4%), while smaller numbers nominated Body Positive staff (11.9%), NZAF staff (6.8%),
HIV GP’s (6.8%) or HIV specialist nurses (6.2%). HIV positive friends were the most common choice (10.5%) for the
third most important source of information about treatments and health management, followed by the internet
(9.2%), staff at Body Positive (9.2%), GP’s (8.5%) and publications from HIV/AIDS groups (7.8%). 
Information about Living with HIV
Responses to the question of important sources of information on living with HIV were divided more evenly between
clinical and non-clinical sources than for the previous item. The source selected by the greatest number of
respondents was hospital-based HIV specialist (37.7%), followed by publications from HIV/AIDS groups (32.6%), HIV
positive friends (32.6%) and HIV magazines and newspapers (28.8%). Staff from HIV/AIDS organisations were also
considered important by significant numbers of positive people (Body Positive staff (others) - 28.4%, Body Positive
staff (treatments-specific) - 27.0%, NZAF staff (others) - 25.1% and NZAF staff (treatments-specific) - 24.2%). 
TABLE 35 Sources of information about living with HIV (percentage of sample)
Source In Paid Not In Paid Total 
Employment Employment Sample
HIV specialist (outpatient) 40.2 34.9 37.7
Publications from HIVAIDS groups 34.8 27.7 32.6
HIV positive friends 38.6 22.9 32.6
HIV magazine/newspaper 32.6 22.9 28.8
Body positive staff (others) 31.1 22.9 28.4
Body Positive staff (treatments-specific) 34.8 13.3 27.0
Internet 29.5 19.3 25.6
NZAF staff (others) 28.0 19.3 25.1
NZAF staff (treatments-specific) 27.3 18.1 24.2
HIV specialist nurse 21.2 15.7 19.1
Articles in gay press 25.0 9.6 19.1
CART 15.9 21.7 18.1
Partner 23.5 9.6 18.1
Other friends 18.2 16.9 17.7
GP 14.4 21.7 16.7
GP with high HIV caseload 16.7 18.1 16.7
Positive Women 12.9 15.7 14.0
Family/Whanau 12.1 14.5 13.0
Publications from other sources 11.4 9.6 10.7
Other HIV/AIDS support organisations 12.1 4.8 9.3
Sexual Health Service 9.8 4.8 7.9
Alternative/Complementary therapist 7.6 7.2 7.9
HIV specialist (inpatient) 9.8 3.6 7.4
Other nurse 7.6 3.6 6.0
Dentist 6.1 2.4 4.7
Other doctor 5.3 2.4 4.2
Dietician 5.3 1.2 3.7
Family planning association 3.8 - 2.3
Pharmacist 2.3 1.2 1.9
Refugee Health Education Program 3.0 - 1.9
Haemophilia society 3.0 - 1.9
Injecting drug users organisation 2.3 - 1.4
NZ Prostitutes Collective 2.3 - 1.4
(Multiple responses possible)
A similar pattern of differences between participants in and not in paid employment can be seen here as was noted
above for treatment information. The differences between these groups are more pronounced in relation to
publications, friends and interestingly, partners. 
When asked to identify the three most important sources of information about living with HIV 26.3% nominated a
hospital-based HIV-specialist, followed by staff at Body Positive (17.2%), HIV positive friends (9.7%) and NZAF staff
(7.5%). The most common choice for the second most important information source was also an HIV-specialist,
followed by a GP, staff at Body Positive (10.8%) and HIV positive friends (8.9%). The internet was the most common
choice for the third most important source of information about living with HIV (11.1%), followed by HIV-positive
friends (9.6%), other friends (8.1%) and a GP (8.1%).
As the internet is seen as an increasingly important, but problematic source of information on HIV, we included two
items to assess how reliable respondents felt the information available was. The responses are presented in Table
36. As can be seen from these data, PLWHA were reasonably sceptical about the reliability of information available
on the net. Those that rated the internet as an important source of information were less sceptical than others. 
TABLE 36 Attitudes to HIV information on the Internet (percentage of sample)
Strongly disagree Disagree Agree Strongly agree Don’t know
Full sample
Information on the internet 7.2 24.0 16.3 3.4 48.6
about living with HIV is unreliable
Information on the internet 7.1 24.1 13.7 1.9 53.3 
about treatment side effects 
is unreliable
Lack of information
We asked respondents whether lack of information made it difficult for them to make decisions in certain areas and
a third (37.7%) agreed that this was the case. When asked to identify the domains in which this applied, 15.8%
nominated the management of side effects (45.3% of those nominating lack of information as a problem) (refer to
Table 37). Employment and financial planning also figured prominently, with 12.6% of respondents identifying lack
of information about work/employment (36.0% of the sub-sample) and 12.6% also nominating lack of information
about financial planning (36.0%). 
TABLE 37 Issues where participants lack information (percent of total sample)
Managing ARV side effects 15.8
Work/employment 12.6
Financial planning 12.6
Legal issues 12.1
Interactions between ARV and other drugs 10.2
Using ARV 10.2
Changing ARV 9.3
Using complementary therapies 8.8
Taking a break from ARV 7.0
Having children 6.5
Recreational drug use 4.2
(Multiple responses possible)
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Publications
Survey participants were asked which publications containing HIV information they read. The results are shown in
Table 38, including breakdowns for specific populations where access or focus is an issue. 
TABLE 38 Publications read by PLWHA
Publication Percent of sample
Collective thinking 44.7
Positively Positive 44.2
New Zealand gay newspapers (% of gay men, lesbians and bisexuals) 38.0
New Zealand gay newspapers (% of total sample) 29.8
New Zealand gay magazines (% of gay men, lesbians and bisexuals) 25.3
New Zealand gay magazines (% of total sample) 20.9
Positive Living (Aus) 17.7
Other websites 16.3
Newsletters from community organisations 13.5
Gaynz.com 11.6
NZAF website 10.7
Overseas HIV magazines (e.g. POZ) 8.8
Overseas gay press 5.6
Australian gay newspapers 4.7
Australian gay magazines 3.3
HIV Australia 2.3
With Complements 1.9
(Multiple responses possible)
INVOLVEMENT WITH AIDS ORGANISATIONS
Participants were asked about their involvement with HIV/AIDS organisations. 62.4% of the sample had some
contact with HIV/AIDS organisations. Of these, 78.2% received newsletters and mail outs, 60.9% were clients, 46.6%
were members, 16.5% were volunteers and 4.5% were employees. Of those that volunteered, they did so for
between 1 and 20 hours per week (median = 6 hours/week). Of those that had no contact with AIDS organisations,
62.5% gave the reason I do not want to be involved, 17.5% gave the reason I do not have enough time, 15.0% said
that they had no transport or are too far away, and 13.8% said they did not know how to join. Only 5% of those who
were not involved in AIDS organisations said they felt excluded from them. 
19.8% of respondents had at some point held a decision making position in an AIDS organisation (9.4% in the last
year). 
Respondents were also asked to list the HIV/AIDS organisations that they had contact with. Over half of the
respondents who listed an organisation said that they had contact with Body Positive (54.7%), while 36.5% had
contact with NZAF, 13.9% with Positive Women, 9.6% with the Burnett centre and 6.6% with CART. 
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THE SOCIAL 
WORLD OF PLWHA 
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This chapter examines the collective experience of HIV from a number of perspectives. While for some
people HIV may be a profoundly isolating experience, the experience of HIV has been overwhelmingly a
collective one. HIV is not only experienced by individuals, but also by communities and social networks. HIV
identity is managed though contact with other positive people, through the disclosure of status, both
willingly and unwillingly, and through engagement with the community sector. Here we explore some of
these issues through the experiences of the respondents to this survey.
CONTACT WITH OTHER PLWHA 
One-fifth of respondents (20.5%) did not personally know anyone else with HIV. Gay men and heterosexual women
were significantly less likely to know no-one else with HIV than other respondents. Over half of respondents had an
HIV positive friend (56.7%) and many had HIV positive acquaintances (41.9%). Around one-quarter either had an
HIV positive partner or ex-partner (24.2% combined). 16.0% of respondents had been involved in the nursing or care
of another positive person at some time in the last two years, and 61.9% have had someone close to them die from
HIV/AIDS. 
TABLE 39 Other HIV positive persons known by respondent
Positive Persons Percentage
Friend 56.7
Acquaintance/Member of support group 41.9
No-one 20.5
Former partner/spouse 12.6
Partner/spouse 11.6
Other relative/Whanau member 3.3
Son/daughter 0.5
Other 3.7
(Multiple responses possible)
More than half of the respondents spent at least some time with other positive people (55.5%). Those who indicated
that they spent either some or a lot of time with other PLWHA were more likely to be those who worked or
volunteered for an HIV/AIDS organisation. There were no significant gender differences in the time spent with other
positive people. 
FIGURE 10 Time spent with other positive people
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DISCLOSURE
Respondents were asked who they had disclosed their HIV status to (see Table 40). Not surprisingly, around three-
quarters (74.0%) had disclosed to close friends, and most (90.4%) of those in relationships had disclosed to their
partner. Within families, people were most likely to have disclosed to siblings (54.9%) although many had disclosed
to parents (45.1%). Only 4.7% had not disclosed their HIV status to anyone. 
TABLE 40 People the respondent has disclosed their HIV status to
Percent who 
have disclosed
Close friends 74.0
Positive friends 42.8
Siblings 54.9
Partner/spouse 54.4
Parents 45.1
Other friends 25.6
Work colleagues 26.5
Son/daughter 13.0
Other family/Whanau members 28.4
Neighbours 13.5
People from own ethnic community 5.1
No-one 4.7
Specific populations
Partners (% of those in a regular relationship) 90.4
Partners (% of those not in regular relationship) 9.6
Work colleagues (% of those currently employed) 27.8
Work colleagues (% of those not currently employed) 25.0
Son/daughter (% of those with dependent children) 20.0
(Multiple responses possible)
Unwanted Disclosure
Respondents were asked if their HIV status had ever been disclosed without their permission. 47.7% said that it had
at some point, and 19.0% said that this had happened in the last two years. A higher proportion of women reported
having experienced unwanted disclosure more than two years prior to survey (38.7% compared with 25.6% of men),
however there was no gender difference in this experience over the previous two years. When asked who disclosed
their status, respondents were most likely to nominate friends (see Table 41). In part these data reflect those that
are most likely to be aware of the respondent’s HIV status. It is concerning that one-fifth (21.4%, 22.5% in the past
two years) reported unwanted disclosure from a worker in a health-care setting.
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TABLE 41 Sources of unwanted disclosure (percentage of those experiencing unwanted disclosure)
Percent  (ever)
Close friends 26.5
Other friends 23.4
Workers in a health care setting 21.4
Work colleagues 18.4
HIV positive friends 17.3
Other family member 13.3
Partner/Spouse 12.2
Parents 12.2
Sibling 11.2
Other 9.2
Neighbour 6.1
Staff/volunteers at community organisation 4.1
Son/daughter 3.0
People from ethnic community 3.0
(Multiple responses possible)
For 65% of those who had had their HIV status disclosed without their permission, this resulted in negative
consequences. This varied to some extent among the sources of unwanted disclosure. For example: when a work
colleague had disclosed, 15 of the 18 participants (83%) said this had negative consequences; when HIV positive
friends disclosed 9 of the 17 (52%) said there were negative consequences; and when a health care worker
disclosed 15 of the 21 (71%) reported negative outcomes. The survey did not have the capacity to detail these
consequences, and this may be an area that could benefit from some detailed qualitative research. 
THE PLACE OF HIV IN PEOPLE’S LIVES
HIV affects many parts of people’s lives in both positive and negative ways. Knowledge of one’s HIV status can be
something that dominates some people’s sense of who they are, while for others it will be a minor facet of their self-
image. These different experiences of HIV status can have significant implications for the provision of services and
the targeting of education for positive people.
To explore this issue, we asked When you think of all the things that make you who you are, how important are each
of the following aspects of yourself? The categories and results are given in Table 42. A rating of essential indicates
that the characteristic is an essential component of the individual’s identity. A rating of important indicates that the
characteristic plays a large part in how PLWHA see themselves, but may have greater or lesser relevance
depending on the context. A rating of not important indicates that the characteristic only has very context specific
relevance and does not generally enter into their self-image. A rating of irrelevant indicates that the characteristic
plays no part in their self-image. While our primary focus in this area was on the importance of HIV identity, we have
included other characteristics, both as points of comparison and as a way of more fully describing PLWHA. The
characteristics examined were sexuality, gender, recreational drug use, ethnicity, parenthood and career. The
majority (48.9%) of positive people in this study considered their HIV status an important, but not essential aspect
of their make-up, while 17.0% considered it to be an essential characteristic. This is in contrast to sexuality and
gender, where around 30% of the sample considered each of these to be essential characteristics.
TABLE 42 Importance of personal characteristics to respondents’ sense of identity
Essential Important Not Important Irrelevant
Sexuality 24.2 45.4 22.7 7.7
Family 35.6 47.8 10.7 5.9
Gender 21.5 46.8 20.5 11.2
HIV status 14.2 55.9 19.6 10.3
Career 20.5 48.0 20.5 11.0
Religious beliefs 11.8 24.0 28.9 35.3
Parenthood 12.1 21.1 16.1 50.8
Ethnicity/Cultural background 8.8 34.8 31.4 25.0
Drug use (recreational/illegal) 5.0 10.4 35.6 49.0
When we look at the importance of HIV status among specific sub groups of PLWHA, we find that there are no
significant differences in terms of sexuality, gender, having had an AIDS defining illness, use of antiretroviral drugs
or partner sero-status (See Table 43).
TABLE 43 Importance of HIV status to sense of identity for different groups of PLWHA
Importance of HIV 
status among: Essential Important Not important Irrelevant
Gay and bisexual men 17.6 52.5 18.1 11.8
Women 7.4 59.3 18.5 14.8
Heterosexual men - 100.0 - -
Those who have had an AIDS 14.3 52.4 26.2 7.1
defining illness
Those who have not had an AIDS 13.5 58.3 17.3 10.9
defining illness
Those on antiretroviral therapy 13.5 58.1 18.9 9.5
Those not on antiretroviral therapy 13.3 53.0 19.7 14.1
Those in seroconcordant 11.5 57.7 26.9 3.8
relationships
Those in serodiscordant 12.9 51.6 21.0 14.5
relationships
SOCIAL SUPPORT
We asked participants about the amount of social support they received from a range of sources including
household members, social contacts and service providers. The ratings are shown in Table 44 below with those for
whom the category was not applicable excluded from each row. Participants were most likely to have nominated
their partner or spouse as providing a lot of support (78.0% of those with partners), followed by PLWHA groups
(51.4%) and close friends (51.3%). When we examine the sources that people rated as providing no support, the
highest ranking category was volunteer carer, where 64.3% of those with a carer said they received no support from
them. Religious or spiritual advisors were also considered a source of no support for 50.7% of those with such a
source. 
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TABLE 44 Social support received from different sources: percent who gave valid 
responses for each category
A lot Some A little None
Partner/spouse 78.0 11.0 5.5 5.5
PLWHA groups 51.4 19.6 19.6 9.3
Close friends 51.3 23.8 15.9 9.0
Parents 46.5 17.8 13.2 22.5
Health care workers 44.4 30.2 23.9 1.5
Siblings 42.4 21.8 17.0 18.8
Children 40.0 16.0 12.0 32.0
Pets 39.3 20.7 17.9 22.1
HIV positive friends 37.2 27.7 19.0 16.1
Family/Whanau 26.8 23.6 28.5 21.1
Doctor 20.7 23.0 29.9 26.4
Religious or spiritual advisor 20.3 15.9 13.0 50.7
Counsellor 20.2 22.5 27.0 30.3
Other friends 18.1 31.6 24.5 25.8
Volunteer carer 9.5 14.3 11.9 64.3
ATTITUDES TO HIV STATUS
Two additional items were included that examine individual’s relationship to their HIV serostatus. Participants were
asked whether they agreed with the statement As long as I am well I prefer not to think about HIV/AIDS. Over half
the respondents agreed or strongly agreed with this statement. The second statement participants were asked to
respond to was Life has become more meaningful since I became HIV positive. Slightly less than half agreed or
strongly agreed with this statement. 
TABLE 45 Attitudes to HIV status
Strongly agree Agree Disagree Strongly disagree
As long as I am well I prefer not 18.4 41.1 36.7 3.9
to think about HIV/AIDS
Life has become more meaningful 15.0 29.6 38.3 17.0
since I became HIV positive
PLANNING FOR THE FUTURE
A core concern of the HIV Futures surveys is how people with HIV view their future, particularly how far into their
future they plan. Less than one fifth (19.9%) planned their life one day at a time and the same proportion (19.9%)
planned only a few months ahead. Over half of the respondents planned for at least a year with 18.0% planning one
year ahead, 18.5% planning five years ahead and 23.7% planning ten years or more ahead. This profile of the
population has changed very little since the first HIV Futures New Zealand survey. Those who had shorter planning
time-frames tended to have lower CD4 counts and to have had an AIDS defining illness. There were no significant
gender differences in time frame for future planning. 
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FIGURE 11 Time frame for future planning
27.5% of respondents reported a change in their time frame for future planning in the last two years. Overall, 11.6%
of all participants now use a shorter time frame than 2 years ago and 14.9% use a longer time frame. The major
reasons for change for those planning further ahead into the future over a longer time frame were improved health
due to new treatments (30.0% of those with longer plans), improved health for other reasons (23.3%) and taking
new treatments (16.7%). The major reason for change for those with a shorter time frame was declining health (37%
of those with a shorter time frame), see Figure 12.
FIGURE 12 Reasons given for change in time-frame
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RELATIONSHIPS
AND SEX
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This chapter reports on a range of issues related to relationships and sexual practice. The HIV Futures
surveys place sexual relationships within the broad context of HIV positive people’s lives. While we do
address the issues of prevention and transmission, we also address the place that sex and relationships play
in the broad social and lived experience of PLWHA. Sex can be a highly emotionally and politically charged
issue for people with HIV, but it can also be unproblematic. An omnibus survey such as this can never hope
to reflect the diversity and complexity of people’s sexual and emotional lives. It can, however, guide us to
where there may be concerns that require additional effort in providing services and support, or where
additional research may be indicated. 
RELATIONSHIPS
Respondents were asked about current sexual relationships. The results are presented in Table 46 below. Almost
one-third of the sample said that they had no sex at present. One-quarter reported that they had a regular
relationship only, while one-quarter said that they had casual sex only, and slightly fewer that they had a regular
relationship plus casual sex. When this item is broken down by sex and sexuality, we find significantly different
patterns between three groups of PLWHA. Heterosexual men were more likely than other PLWHA to report that they
had no sex at present. Women were more likely to report that they had one regular sexual partner and no casual
sex. Gay and bisexual men are more likely to report that they had a regular sexual partner and also had casual sex. 
TABLE 46 Type of sexual relationship(s) by gender and sexuality of respondent (percentage)
Gay or Heterosexual Women Total
Bisexual Men men
I have no sex at present 25.9 66.7 50.0 31.9
I have casual sex only 31.5 - - 25.0
I have a regular relationship 
with one person, and I have 
sex with other people 20.4 - - 16.2
I have a regular relationship with 19.8 33.3 50.0 25.0
one person, and I do not have 
sex with other people
I have a regular relationship 2.5 - - 2.0
with two or more people
When asked if they were currently in a regular relationship, 42.5% said they were, which is similar to the proportion
of the sample that report having sex with a regular partner in Table 25 above (43.2%). The proportion of gay or
bisexual men reporting having a regular partner (42.7% from Table 46) is lower than that reported for HIV negative
and unknown HIV status MSM in the most recent GAPSS survey (54.1%) (Saxton et al 2006)
Regular Partners
Of those in a relationship with a regular partner, 27.6% reported that their partner was also HIV positive (generally
described as a sero-concordant relationship). The remainder were in serononconcordant relationships. This
remaining group is made up of 65.3% of those in relationships that report that their partner is HIV negative (a sero-
discordant relationship) and 7.1% who report that they don’t know their partner’s HIV status. Nearly all PLWHA
(97.9%) had told their regular partner that they were HIV positive. 
Respondents were asked at what point in the relationship they told their partner. The responses are given in Figure
13 below. Almost one-half of respondents had told their partner when they themselves found out they were positive
(46.3%). 17.9% said that their partner knew their HIV status prior to the start of the relationship, while 15.8% had told
their partner when the relationship started. Small numbers of respondents (8.4%) had told their partners a few days
into the relationship, 8.4% a few weeks into the relationship, 2.1% a few months into the relationship and 1.1% a
year or more into the relationship. 
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FIGURE 13 Time HIV status disclosed to partner among those in regular relationships
When asked how their partner responded when told of the respondent’s HIV status, the majority (52.3%) reported
that the partner was supportive (see Table 47). Over one-third (38.5%) reported that it did not make any difference
and 29.4% reported that the disclosure brought them closer together. Just under one-third (31.2%) reported that
their partner was worried or scared and 6.4% said their partner was angry. 
TABLE 47 Reaction of partner to disclosure: percentage of those in regular relationships
They were supportive 52.3
It did not make any difference 38.5
We became closer 29.4
They were worried / scared 31.2
They were angry 6.4
(Multiple responses possible)
We also asked how the respondent themselves felt about this disclosure. Half (50.5%) said they were worried about
their partner’s reaction, 40.4% said they were relieved and one-third said it brought them closer to their partner. 
We have reported the data in the following tables on sexual practice and condom use in numbers rather than
percentages, as the small sub-samples would give an inflated view of the proportions in some categories. PLWHA
in regular relationships were asked about the sex they had with their regular partner. Overall, 40.4% of the total
sample had anal or vaginal sex with a regular male partner in the six months prior to completing the survey and
3.9% had anal or vaginal sex with a regular female partner in the previous six months. Condom use with regular
partners can be seen in Table 48 below.
TABLE 48 Condom use with regular partner by respondent and partner gender (Number of these that
used condom (N=82))
Never Sometimes Usually Always
Female respondents N=14
With regular male partner 2 2 5 5
Male respondents N=68
With regular male partner 6 9 10 41
With regular female partner 1 0 1 0
We can examine these data in terms of relationship sero-concordance and this gives some additional context to
condom use. The small numbers involved, however, mean that this level of detail should be treated with great
caution. Unprotected vaginal or anal intercourse is more likely to have occurred in sero-concordant relationships
than in sero-nonconcordant relationships (see Table 49).
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TABLE 49 Condom use with regular partner by respondents’ gender, partner gender, and 
partner sero-status (Number of these that used condom)
Never Sometimes Usually Always
SERO-CONCORDANT Relationships N=17
Female respondents N=4
With regular male partner 1 1 2 -
Male respondents N=13
With regular male partner 4 1 - 8
With regular female partner
SERO-NONCONCORDANT Relationships N=43
Female respondents N=8
With regular male partner 1 - 3 4
Male respondents N=35
With regular male partner 2 4 5 23
With regular female partner 1 - - -
Casual Partners
Over half (51.7%) of the sample reported that in the six months prior to completing the survey they had had sex with
one or more casual partners. When asked the HIV status of their casual partners, 4.7% reported that all of their
casual partners were HIV positive, 14.0% reported that some of their casual partners were HIV positive, and 6.5%
reported that none of their casual partners were HIV positive. Most (74.8%) respondents who had had casual sex
reported that they did not know the HIV status of their casual partners. Respondents were asked about their
condom use during anal or vaginal intercourse with casual partners over the previous six months. As can be seen
from Table 50 there is some variation in condom use when we examine this by sex of respondent and sex of partner. 
TABLE 50 Condom use with casual partner by respondent and partner gender 
(Number of these that used condom (N=88))
Never Sometimes Usually Always
Female respondents N=2
With casual male partners - - - 2
Male respondents N=86
With casual male partners 2 7 18 54
With casual female partners - - 2 3
Again, when we look at these data in terms of the partners’ HIV status there is some suggestion that there is a
relationship between sero-concordance and condom use (see Table 51). The small numbers involved here mean
that these findings should be treated very cautiously. 
TABLE 51 Condom use with male casual partner by partners’ sero-status 
(Number of these that used condom (N=81))
Casual partners’ HIV Status Never Sometimes Usually Always
All HIV positive 1 - - 3
Mixture/unsure 1 6 18 50
All HIV negative - 1 - 1
In addition to reporting on their overall patterns of condom use, respondents who had had casual sex reported on
their most recent sexual encounter with a casual partner. Half of the survey respondents (49.3%) provided such
information. Of the respondents who had casual sex, 70.5% had vaginal or anal intercourse on their last occasion
with a casual partner. As was found for the overall patterns of condom use, condom use during respondents’ most
recent sexual encounter was contingent on the HIV status of the partner. Figure 14 gives a breakdown of the range
of protective strategies employed by positive people to protect their most recent casual partner. This includes
knowledge of HIV status, condom use and avoidance of ejaculation within their partner. This schematic shows that
for the entire set of data available, incidents that involved any risk were very rare and mostly associated with
partners of unknown status. 
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FIGURE 14: Sexual practice with the most recent casual partner
Sex with a casual partner in the last six months?
No Yes
100     107
(48.3) (51.7%)
Anal/vaginal intercourse with most recent casual partner? (missing=2)
No Yes
31     74
(29.5%) (70.5%)
HIV status of casual partner (missing=0)
HIV positive HIV Negative Status Unknown
6 9 59
(8.1%) (12.2%) (79.7%)
Condom used? (missing=1)
Yes No Yes No Yes No
4 2 9 0 52 6
(66.7%) (33.3%) (100.0%) (-) (89.7%) (10.3%)
Ejaculated in partner? (male respondents only) (missing=0)
No Yes No Yes No Yes
1 1 0 0 5 1
(50.0%) (50.0%) (-) (-) (83.3%) (16.7%)
(0.5% of total) (0.5% of total)
Ejaculated in by partner? (male partners only) (missing=0)
No Yes No Yes No Yes
1 1 0 0 2 4
(50.0%) (50.0%) (-) (-) (33.3%) (66.7%)
(0.5% of total) (1.9% of total)
Respondents who indicated that they knew their partners’ HIV status were asked how they knew. Nearly all (88.9%)
of these respondents said that their partner had told them their status, while 48.6% (n=17) said that they knew their
partner’s status from the type of sex they wanted and 41.2% (n=14) said that someone else told them of their
partner’ status. Five respondents said they could tell by the people they were with and one said that they could tell
by the bar/venue at which they met.
16.0% of respondents said they told their most recent casual partner that they were HIV positive, 66.0% did not,
13.2% said the partner already knew they were HIV positive and 4.7% could not recall. 
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LEGAL ISSUES AROUND DISCLOSURE OF HIV STATUS
The law in New Zealand is clear that people who are HIV positive are not criminally liable when there is condom use
and disclosure or condom use and no disclosure. Therefore it is not legally necessary for PLWHA to disclose their
HIV status to sexual partners if a condom is properly used (www.nzaf.org.nz/articles.php?id=509). Notwithstanding
this, there are provisions under the Crimes Act (1961 §144 and §188(2)) for the prosecution of people with HIV for
exposing someone to HIV, or infecting someone else with HIV without taking ‘reasonable precautions’. There have
been convictions under this legislation where there was no disclosure and no condom use. The existence of this
legislation and uncertainty around the implications for PLWHA has led to a degree of anxiety in the positive
community (and indeed among the gay male community) around issues of disclosure, negotiated condom use and
potential stigma and discrimination. Between the first HIV Futures New Zealand Survey and the current one, this
legal situation was clarified to an extent through the outcome of a high profile court case (Police V Dalley), where
the ruling made clear that condom use in the absence of disclosure constituted ‘reasonable precautions’ (DC,
Wellington, CRI-2004-085-009168, 4 October 2005, Judge SE Thomas). 
In order to understand the extent to which they were aware of these laws, respondents were asked to respond to
two statements concerning disclosure of HIV status to sexual partners (Table 52). Over half of respondents (63.1%)
agreed that it is legally OK for someone to use a condom for anal or vaginal sex and not to tell their partner about
HIV status. However one-quarter of respondents disagreed with this statement and 11.5% said they didn’t know.
Gay men were most likely to agree with this statement (72.6%). Similarly, 61.1% of respondents disagreed that it is
legally OK for a person to disclose their HIV status to a partner and then not use a condom for anal or vaginal sex.
Slightly less than one-quarter (23.0%) agreed with this statement, while 15.8% said they didn’t know. There were no
differences in responses to this item based upon sexuality. 
Respondents were also asked how the legal situation concerning disclosure has affected their relationships. More
than half (62.4%) disagreed that the current legal situation about disclosure about HIV status has limited my ability
to form new relationships. However around one-third (31.0%) agreed with this statement. Again, there were
differences in responses to this item based upon sexuality.
TABLE 52 Attitudes to legal issues around disclosure
Strongly disagree Disagree Agree Strongly agree Don’t know
Currently it is legally OK for 10.5 14.8 41.6 21.5 11.5
someone to use a condom 
for anal or vaginal sex and 
not to tell their partner about 
HIV status
Currently it is legally OK for 30.1 31.1 18.2 4.8 15.8
a person to disclose their HIV 
status to a partner and then not 
use a condom for anal or vaginal sex
The current legal situation 16.2 46.2 23.9 7.1 6.6
about disclosure about HIV status
has limited my ability to form 
new relationships
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HIV, SEX, RELATIONSHIPS AND TREATMENTS
PLWHA were asked to respond to a number of statements about relationships, sex and HIV. The results of these
items are shown in full in Table 53. 
When asked whether they would prefer to be in a relationship with someone who is also HIV positive, around one-
quarter (26.7%) said they would, just under half (47.1%) said they would not, and the remainder (26.2%) said that
they did not know. 
The potential to develop new relationships remains an important issue for PLWHA. While much has been done to
reduce stigma and discrimination in formal settings such as workplaces and healthcare settings, the more intimate
domains of sex and relationships can still be a site of anxiety and uncertainty for both HIV positive and negative
people. Two-thirds (67.2%) of the respondents agreed with the statement Few people would want a relationship with
someone who has HIV. A similar response was found to the statement I am afraid of telling potential partners of my
HIV status in case they reject me. Over half the respondents (58.9%) agreed with this statement. 
Concerns about transmission of the virus to others and re-infection were apparent in the responses to the next six
items. Most respondents (72.9%) agreed with the statement I am afraid of infecting my partner, or potential partner,
with HIV, while very few agreed with the statements I feel more confident about unprotected sex because of the new
treatments and Undetectable viral load means HIV is unlikely to be transmitted to a sexual partner even if I have sex
without a condom. However around one-third agreed with the statement Withdrawing before ejaculating (cumming)
is a way to reduce the risk of passing on HIV (29.8%). Those having casual partners were more likely to agree with
this item. 
The potential impact of vaccines on intentions to practice safe sex and anxiety about safe sex was minimal with only
20.2% agreeing with the statement If there was a vaccine which prevents HIV, I would not practise safe sex, and
14.4% agreeing with the statement Knowing that a vaccine will become available makes me less anxious about sex. 
The response to concerns about re-infection remains mixed, with 51.7% agreed that I am concerned about
becoming infected with another strain of HIV, while 36.9% disagreed. 
When we examine the impact of HIV on sexual pleasure, we find that the majority of the respondents (65.5%) agreed
with the statement HIV has had a negative effect on my sexual pleasure. One third (29.1%) disagreed with this
statement. 
When asked about the relationship between partners’ HIV status and sexual pleasure there was a greater degree
of uncertainty. 27.2% were unsure when asked to respond to the statement If I know that my partner is HIV positive
I find sex more pleasurable. More respondents disagreed with this statement (51.3%) than agreed with it (21.4%).
Those who disagreed were more likely to be those who were in a sero-discordant regular relationship, or whose
casual sexual partners were mostly HIV negative. 
Over a third (35.9%) said that they agreed with the statement I have stopped having sex because of my HIV status.
Similarly, 56.1% of participants agreed that HIV has negatively affected my libido. 
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TABLE 53 Attitudes to HIV, sex and relationships
Strongly disagree Disagree Agree Strongly agree Don’t know
I prefer to have a relationship 13.1 34.0 14.6 12.1 26.2
with someone who also 
has HIV
Few people would want a 1.9 20.3 43.0 24.2 10.6
relationship with someone 
who has HIV
I am afraid of telling potential 9.2 21.5 37.9 21.0 10.3
partners of my HIV status in 
case they reject me
Being HIV positive has helped 22.7 38.9 17.7 5.1 15.7
me form more satisfying 
relationships
I am afraid of infecting my 8.5 14.1 37.2 35.7 4.5
partner, or potential partner, 
with HIV
I feel more confident about 62.4 23.8 4.5 2.5 6.9
unprotected sex because of 
the new treatments
Medical treatments for HIV/AIDS 54.7 27.4 7.5 3.3 7.1
make safe sex less important 
than it was
Withdrawing before ejaculating 32.8 28.8 21.7 8.1 8.6
(cumming) is a way to reduce the 
risk of passing on HIV
If there was a vaccine which 26.6 36.9 15.8 4.4 16.3
prevents HIV I would not practice 
safe sex
Undetectable viral load means 49.1 28.0 6.1 4.2 12.6
HIV is unlikely to be transmitted 
to a sexual partner even if I have 
sex without a condom
Knowing a vaccine will become 22.6 41.0 11.8 2.6 22.1
available makes me less anxious 
about sex
I am concerned about becoming 8.5 28.4 40.3 11.4 11.4
infected with another strain of HIV
HIV has had a negative effect on 6.4 22.7 37.4 28.1 5.4
my sexual pleasure
If I know that my partner is HIV 22.0 29.3 14.1 7.3 27.2
positive I find sex more pleasurable
I stopped having sex because of 16.9 45.6 21.0 14.9 1.5
my HIV status
HIV has negatively affected my 10.7 24.9 33.2 22.9 8.3
libido
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CHILDREN
As mentioned in the description of the sample earlier in this report, 28.2% of those surveyed, including 54.8% of
women (n=17) and 22.9% of men (n=40), had children, while 7.0% (9 women and 6 men) had dependent children
living with them. We were also interested in future plans for children among PLWHA. Most PLWHA (69.5%) were not
currently considering having children. Of the remainder, 9 had decided to have children in the future and 1 was
attempting to have children. Eleven were considering having a child, but have not decided, and 7 people have
considered having a child, but have decided it is too risky. Two respondents said they did not have enough
information to make a decision. As can be seen in Table 54 this was an issue of interest to women, gay men and
heterosexual men
TABLE 54 Planning to have children (number)
Gay or Heterosexual 
Bisexual Men men Women Total4
No 127 4 10 141
No, I already have children 17 2 8 27
I have decided to have a child / children 2 3 4 9
in the future
I am currently trying to conceive / get pregnant - - 1 1
I am currently pregnant - - - -
I have thought about it but I haven’t decided 6 2 3 11
I have thought about it but I have decided 5 - 2 7
that it is too risky
I was told not to by a doctor/ medical professional - - - -
I don’t have enough information to make a decision 2 - - 2
4 Total is larger than sum of previous categories due to missing data
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RECREATIONAL 
DRUG USE
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PRACTICES
Respondents were asked about their use of a range of non-prescription drugs, both those legally available and
those that are currently prohibited in New Zealand. Respondents were asked which of a list of substances they had
used in the last twelve months. For those drugs which are commonly injected, differentiation was made between
injection and other means of administration. Table 55 gives these results. As can be seen from these data, alcohol
was the most commonly used drug followed by tobacco. The New Zealand Census reports a population cigarette
smoking rate of 18.91% (Statistics New Zealand). The 2003 Health Behaviours survey (Ministry of Health 2007b)
reports alcohol use among the New Zealand population at 81.2%. Other drugs that are popular in the gay and
dance party scenes (amyl and ecstasy) were also used by PLWHA. These drugs are used at higher rates than the
New Zealand population as reported by the Health Behaviours Survey (Ministry of Health 2007b) which gives rates
in the 12 months prior to survey of 13.7% for cannabis, 2.5% for amphetamines, and 1.9% for ecstasy. 
TABLE 55 Recreational use of drugs in previous 12 months (Percentage of sample)
Alcohol 75.3
Cigarettes 37.7
Marijuana 34.4
Amyl 28.4
Viagra or similar 14.0
Ecstasy 8.4
Crystal Meth 4.7
Speed (not injected) 1.9
Cocaine (not injected) 1.9
Speed (injected) 1.4
Methadone (prescribed) 1.4
GHB/GBH/Fantasy 0.9
LSD/trips 0.9
Steroids (injected) 0.9
Homebake 0.5
Methadone (other) 0.5
Heroin (injected) -
Cocaine (injected) -
Heroin (not injected) -
Other 2.8
(Multiple responses possible)
It must be noted that we only asked respondents if they had used each of the drugs in the previous twelve months,
not how often they use them. Use of many drugs is occasional rather than regular and this may inflate the rates
reported here. 
4.4% of PLWHA reported that they have had a bad experience from using both antiretroviral drugs and illegal drugs.
11.1% reported that they had missed a dose of antiretroviral medication at some point as a result of using illegal
drugs. 
Most respondents (84.8%) reported that they had never injected illegal drugs. Of who had injected illegal drugs,
23.8% had done so in the previous 12 months. Of PLWHA who reported injecting drugs, none had shared injecting
equipment in the past twelve months. 
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ATTITUDES RELATING TO DRUG USE
Around one quarter (23.4%) of respondents felt that they drank more alcohol than they would like, while only 8.2%
felt they had used more illegal drugs than they would like. 
We asked participants to respond to two items about needle sharing and transmission that were similar to those
asked about sex: I worry about infecting others by sharing needles and sharing needles is not a problem if your viral
load is undetectable. The low number of respondents who have shared needles is reflected in the not applicable
responses to these items. 
TABLE 56 Attitudes relating to drug use and infection (percentage of full sample)
Strongly disagree Disagree Agree Strongly agree N/A
Total sample
Sharing needles is not a 46.3 5.4 - 2.0 46.3
problem if your viral load 
is undetectable
I worry about infecting others 4.9 0.5 2.9 7.8 83.8
by sharing needles
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HOME, WORK 
AND MONEY
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ACCOMMODATION
We asked a series of questions about participants’ accommodation status and experiences. These experiences
vary considerably among PLWHA, most particularly as a function of whether individuals are in private or public
accommodation. 
Current Accommodation
The current type of accommodation of the respondents can be seen in Table 57. Similar numbers of PLWHA were
in accommodation that they owned or rented through the private system. A smaller number of people were in public
rental accommodation. This group were more likely to be those on a government benefit. There were no significant
gender differences in the type of accommodation reported. 
TABLE 57 Current accommodation of respondents (percentage of total sample)
Own or purchasing house or flat 45.6
Private rental accommodation 30.7
Public rental accommodation(government owned) 13.0
Rent-free (e.g. provided by friends, family, etc.) 6.5
Community housing/housing co-operative -
Other 4.2
These findings can be compared to data from the New Zealand Census (Statistics New Zealand) which reports that
66.9% of the population own or are paying off their current dwelling, and 33.1% do not own their current dwelling.
Rental rates are reported in the census as a proportion of those who do not own their current dwelling (85.9%)
(Statistics New Zealand) so this can be read as 28.4% of the population being in a rental arrangement. From these
data we can also calculate that 23.2% of the population were living in private rental accommodation and 5.2% in
public rental accommodation. Similarly the percentage living rent free can be calculated as 4.2%. The PLWHA
population can, therefore, be seen to have lower rates of home ownership and higher rates of public rental than the
remainder of the population. 
Household composition varied considerably. 29.8% of PLWHA lived alone (compared to the Census rate of 22.6%,
Statistics New Zealand), while the remainder lived with between 1 and 15 other adults (median=1) and with
between 1 and 5 children (for those living with children: median=2). Two fifths (40.0%) lived with a partner or
spouse, and 7.0% lived with dependent children. These children ranged in age from less than 1 to 47 (mean=24.0,
median=26.0). In addition, 12.6% lived with other family members and 16.7% with friend(s) or flatmate(s). Half
(50.9%) of PLWHA also lived with pets. Respondents with pets were as likely to live on their own as with others, and
as likely to have a regular partner as not. 
Respondents most commonly lived in residences with three bedrooms (40.2%) (Census 46.3%), while the
remainder had 2 bedrooms (29.9%) (Census 19.8%), 1 bedroom (15.0%) (Census 5.8%), 4 or more bedrooms
(14.5%) (Census 28.1%) or lived in a bedsit/studio (0.5%) (Census 0.7%). 
81.9% of respondents had access to a car (Census 88.1%). When asked how easy it was to access public
transportation, 14.6% said it was very difficult, 15.0%, difficult, 40.4% easy and 30.0% very easy. 
88.7% of respondents stated that their accommodation was suitable for their current needs. Of those who said their
accommodation was unsuitable (N=24), the main reasons given were that it was too small (n=12), was too
expensive (n=9) and lacked privacy (n=7).
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TABLE 58 Reasons current accommodation is unsuitable 
(number of those with unsuitable accommodation)
Too small 12
Too expensive 9
Lack of privacy 7
Confidentiality problems 6
Inadequate facilities for carer(s) 5
Too far from other services 5
Too far from health services 4
Poor condition of housing 2
Fear of violence 2
Inadequate for my current state of health 2
Harassment 2
Other 4
(Multiple responses possible)
Changes in Accommodation
Participants were asked if they had ever changed their accommodation as a result of having HIV/AIDS and 23.3%
had, 9.3% in the past two years. On average all PLWHA had changed their accommodation 1.9 times ever as a
result of HIV/AIDS (1.7 times in the last two years). 
We asked what the circumstances were around participants’ last change in accommodation. The results are shown
in Table 59 below. Finances, health and location were all important factors in making a decision to move. When
asked if they had any other accommodation options for the future, 60.9% (n=14) of those who said their
accommodation was unsuitable said they did not.
TABLE 59 Reasons for changing accommodation (number of respondents)
Needed cheaper housing 19
Moved closer to health services 13
Illness 13
Moved to a quieter location 11
Lack of privacy 9
Stopped working 9
Better health 8
Planning for illness 7
Moved closer to friends 7
Looking for/returned to work 7
Ending of relationship 6
Improved finances 6
To avoid harassment 4
Moved closer to other services 4
Moved out of family home 4
Moved in with family 3
Beginning of new relationship 1
Other 10
(Multiple responses possible)
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EMPLOYMENT
The area of employment continues to present challenges to HIV positive people. While the need for financial
security, social contact and a sense of worth are critical factors in HIV positive people’s wishes to be in paid
employment, the management of HIV disclosure, the intermittent effects of illness and the need for flexibility around
taking time off can prove substantial barriers to obtaining and retaining employment. There are also considerable
obstacles for those who have left employment in the past and are attempting to return to the workforce. These
include the loss of appropriate skills due to changes in the work environment, explaining an extended absence from
the workforce, issues of aging and changes in life goals.
Employment Status
Over half (61.7%) of the respondents were currently employed, with considerably more being in full-time work
(43.9%) than in part-time work (17.8%). The remainder tended to describe themselves as either unemployed
(13.1%) or not working/retired (12.8%). Compared with the full sample, a smaller proportion of women were
employed (45.2%), with 32.3% (n=10) being in full-time work and 12.9% (n=4) in part-time work. This compares
with New Zealand Census data that indicate that 48.4% of the adult population is in full time employment and 14.4%
in part time employment (Statistics New Zealand) 
Of those who were working, the mean number of hours worked was 38.6 (median=40.0) (Census median and
mode= 40 hours). Those working full time worked an average of 44.9 hours per week (median=40.0) and those in
part time employment worked an average of 24.1 hours/week (median=23.0). Those who were not working
stopped work between 1982 and 2006 (mean=2001, median=2004). 
TABLE 60 Employment status (percentage of sample)
Work full-time 43.9
Work part-time 17.8
Not working / Retired 12.6
Unemployed 13.1
Student 4.2
Home duties 3.3
Other 5.1
FIGURE 15 Employment status
 
Home duties 3.3% Other 5.1%
Work full-time 43.9%
Work part-time 17.8%
Not working 
Retired 12.6%
Unemployed 13.1%
Student 4.2%
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Impact of HIV and Treatment on Employment
We asked respondents how their initial HIV diagnosis affected their career plans and how their plans had changed
since then. These data are shown in Table 61 and Table 62 below. A large proportion indicated that their career
ended at their time of diagnosis (16.6%).
TABLE 61 Impact of HIV diagnosis on career plans (percentage of sample)
My career plans did not change 37.1
It was more difficult to plan for the future 25.4
My career ended/I stopped work 16.6
A career was no longer as important 12.7
I changed careers 6.8
I was less likely to change careers 1.5
HIV also has a negative impact on the continuing work lives of HIV positive people. When asked what the ongoing
impact of HIV was on their work life and career plans, one in five (22.1%) said that they found planning for the future
more difficult, while smaller numbers said that their career was no longer as important (15.2%) or their career
ended/they stopped work (13.2). There were no significant gender differences in the impact of HIV diagnosis or
subsequent experience on career plans. 
TABLE 62 Ongoing impact of HIV on career/work
My career plans have not changed 35.3
It is more difficult to plan for the future 22.1
A career is no longer as important 15.2
My career ended/I stopped work 13.2
I changed careers 8.8
I am now less likely to change careers 5.4
We asked about the impact of antiretroviral therapy on respondents’ career plans (see Table 63 below). Of those
that have used antiretroviral medication, the most common response was that this had not affected their plans. 
TABLE 63 Impact of antiretroviral therapy on work 
(percentage of those who have used or are using ARVs)
There has been no change to my plans 36.5
I anticipate a longer time in the workforce 13.5
I stopped work 12.8
I made a new career plan 9.6
I considered a new career plan 5.1
I went back to work 5.8
I considered going back to work 3.9
I considered stopping work 3.8
Other 7.1
Interruptions to Employment
Respondents were asked if they had stopped work at any time since their HIV diagnosis. Of those who have
worked, 41.5% had stopped work for reasons related to HIV at some point. Of those who had ever stopped work,
53.3% had stopped work on one occasion, 25.3% on two occasions, and 12.0% on three occasions. These work
interruptions averaged 3.9 years (median= 2 years). The circumstances relating to the most recent interruption to
employment are given in Table 64 below. The most common responses were poor health and diminished energy
levels. Around half of those who had ever stopped work due to HIV reported that psychological health (stress,
depression or anxiety) had played an important role in the decision.
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TABLE 64 Circumstance surrounding last interruption to employment 
(percentage of those who had stopped work)
Poor health 69.2
Low energy levels 55.1
Stress, depression, anxiety 52.6
To have more time to myself 20.5
Expecting illness in the future 9.0
To move to a different location 7.7
Redundant/sacked 7.7
To care for another HIV positive person 2.6
Other 7.7
(Multiple responses possible)
These circumstances are also reflected in the participants’ HIV/AIDS status at the time they ceased work. Nearly
half said that they were ill at the time, although importantly, over one third said that they were not ill at the time,
perhaps reflecting both the anticipation of illness and the psycho-social impact of HIV.
TABLE 65 HIV/AIDS status at time of last interruption to employment
I had HIV and had been ill 35.5
I had HIV but had not been ill 51.3
I had been diagnosed with an AIDS-defining illness 13.2
We asked participants their source of income during their most recent interruption to employment. Over half said
they relied on a government benefit of some sort. 
TABLE 66 Source of income when not working
Benefits / pension / social security 60.5
Salary 13.2
Superannuation / annuity / savings 10.5
Partner supported me 9.2
Family / friends supported me 2.6
Other 3.9
Of those that stopped working at some point, 66.2% had returned to work. This was most commonly for financial
reasons (see Table 67), although better psychological health, better physical health and the need to perform
meaningful tasks were also important.
TABLE 67 Reasons for returning to work
Financial reasons 55.1
Better psychological health 42.3
Better physical health 39.7
To do something worthwhile 37.2
To have something to do 35.9
To have more social contact 25.6
The possibility of working part-time 20.5
The possibility of flexible work hours 15.4
The possibility of working full-time 11.5
Other 6.4
(Multiple responses possible)
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Those Currently in Paid Employment
Respondents were asked about the level of stress in their current job. Almost one half rated the stress level as
moderate (43.8%) while 32.8% said it was high and 10.2% said it was very high. Only 0.8% rated the stress level as
very low and 12.5% said there was low stress (see Figure 16)
FIGURE 16 Stress at work
Confidentiality in the workplace remains a critical and complex issue for positive people, particularly given ongoing
experiences of discrimination. When asked what difficulties they experienced around confidentiality at work, 12.6%
said that they did not attempt to keep their status confidential (see Table 68). 41.9% said they had experienced no
problem in this area. Of those who did experience difficulties, the greatest problem appeared to be gossip, followed
by issues around explaining absences from work, and visible signs of illness. 
TABLE 68 Difficulties with HIV status confidentiality in the workplace: percent of total sample
No problems 41.9
I do not try to keep my HIV status confidential 12.6
Gossip 7.4
Visible signs of illness 7.0
Explaining absences from work 6.5
Difficulty keeping and taking medication 3.7
Other  0.9
(Multiple responses possible)
When asked how many people in their workplace knew that they were HIV positive, 6.3% said that everyone knew,
10.2% said most people knew, 16.4% said a few people knew, 16.4% said one person knew and 50.8% said 
no-one knew (see Figure 17). 
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FIGURE 17 Disclosure in workplace
When asked about the impact that HIV had on their capacity to perform their work duties, one-third of the sample
said that their work was unaffected, while just over one-quarter said that they tired more quickly (see Table 69). 
TABLE 69 Impact of HIV on work capacity (percentage of those in paid employment)
It is not affected 33.5
I tire more quickly 26.5
I work reduced hours 10.7
I have difficulty concentrating 10.2
I cannot always go to work 6.5
I do different duties 5.1
I am less productive 3.3
Other 1.4
(Multiple responses possible)
Living with HIV often involves intermittent periods of ill health, particularly around treatment changes and the need
to access health and other services, often only available during work hours (Prestage et al. 2001). Respondents
were asked how much flexibility their workplace gives them to take time off for reasons relating to HIV. Most PLWHA
had the capacity to take time off for medical appointments (see Table 70) and illness. There was less capacity to
take time off for counselling and few had much capacity to take time off to engage in volunteer work.
TABLE 70 Capacity within workplace for HIV related interruptions 
(percentage of those in paid employment)
never seldom sometimes often always
For medical appointments 5.8 2.5 15.0 15.8 60.8
For counselling 26.9 6.4 12.8 10.3 43.6
When you are sick 3.5 2.6 16.7 14.0 63.2
To do volunteer work 52.1 17.8 12.3 - 17.8
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Anticipated Changes in Work for Those Working and Those Not Working
Respondents were asked if they currently had plans to change their work arrangements, and 36.8% said they did.
Of those who described themselves as unemployed, 50.0% said they were planning to return to work. 
TABLE 71 Plans for changes to work life (percentage of employed respondents)
Full time Part time Total working sample
I want to stop work 3.2 2.6 3.0
I want to change the type of work I do 14.9 26.3 18.2
I want to reduce my work hours 6.4 15.8 9.1
I want to increase my work hours 1.1 23.7 7.6
The main incentives for changes in work arrangements were financial and social (see Table 72). 
TABLE 72 Reasons for changes to work plans among full sample.
Financial reasons 22.8
Better psychological health 20.9
To do something worthwhile 18.6
Better physical health 15.3
To reduce stress 14.9
To have more social contact 14.0
To have something to do 11.2
The possibility of flexible work hours 7.0
The possibility of working part-time 5.1
The possibility of working full-time 4.2
To have less social contact 1.9
Worse physical health 0.9
Worse psychological health -
(Multiple responses possible)
Leisure
Respondents were asked how they spend their time while not working. Each respondent indicated the three
activities that occupy most of their time. Almost two-thirds indicated that leisure activities (for example reading)
occupied their time. Slightly fewer identified housework and resting, while half said they spent their time socialising.
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6 Ns refer to the number of participants that identified this as an applicable cost. That is, those selecting “not applicable” or giving no
response are excluded from the percentages reported in that row.
TABLE 73 Activities pursued while not working: percentage of total sample
Leisure activities (reading, etc.) 63.7
Housework / chores 61.4
Resting 60.0
Socialising with close friends 49.8
Spending time with family 34.0
Socialising with other friends 14.9
Looking after children 10.2
Socialising with HIV positive friends 9.3
Volunteer work in HIV/AIDS organisation 7.9
Volunteer work in other organisation 9.8
Looking after another HIV positive person 2.8
(Multiple responses possible)
FINANCES
The HIV Futures surveys have highlighted the financial difficulties that many PLWHA contend with. These difficulties
cannot be explained simply by the proportion of PLWHA relying on government pensions or benefits. There are
financial hardships associated with being HIV positive. Some of these are structural and systemic, for example the
costs associated with managing the negative consequences of treatment, some result from stigma and
disadvantage that result from reduced employment options, while others are the cumulative effects of living for
many years with uncertain or fluctuating health and well-being. 
Income
The source of income of the survey respondents is shown in Table 74 below. The most common income source
was salary, nominated by just under half of the sample (45.7%) (Census 59.9%), while around one-third relied on
government pensions or benefits (35.6%). Compared with the full sample, a smaller proportion of women
nominated salary as their main income source (32.3%, n=10), while a higher proportion nominated a benefit
(45.2%, n=14) or their partner (16.1%, n=5). Data from the 2006 Census indicate that 18.1% of adults aged 15
years and over received a non-superannuation government benefit, including 2.4% that receive a sickness benefit
and 3.1% that receive an unemployment benefit (Statistics New Zealand). The proportion of respondents listing their
main income source as salary was higher than in the previous HIV Futures New Zealand survey (45.7% compared
with 38.8% in 2001), while the proportion relying on a benefit was lower (35.6% compared with 46.8%). This may be
partly due to the increase in the proportion in full-time employment. Much smaller proportions listed
superannuation, their partner or family as their main income source.
TABLE 74 Primary source of income: percentage of total sample
Salary 45.7
Benefits/pension/social security 35.6
Superannuation/annuity/savings 7.2 (n=15)
Partner supports me 2.9 (n=6)
Family/Whanau/friends support me 1.4 (n=3)
Other 7.2
The median weekly in-hand income for respondents was $486. Figure 18 below gives the distribution of income in
$100 intervals. 23.3% of respondents had a partner with whom they shared financial resources. The partner’s
median weekly income was $600.
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FIGURE 18 Histogram of respondents’ weekly income after tax
Income Comparison with the New Zealand Population
We can compare the incomes of the PLWHA who completed this survey with those of the New Zealand population
through data collected by the New Zealand Income Survey (Statistics New Zealand). In our 2001 report we used a
poverty line set at 60% of the median household income to assess financial hardship among PLWHA. Due to
complex changes in the distribution of income in New Zealand and the disproportionate impact of tax law, non-
salary income and geography, we do not consider this measure to provide a meaningful representation of the
relative economic position of PLWHA, nor an adequate method of assessing changes in economic status between
the two surveys. 
In this report we have chosen to examine financial status by direct comparison with the distribution of New Zealand
income, by examining change in income relative to changes in the Consumer Price Index (CPI), by examining
adjusted household incomes using the Jensen Equivalence scale values, and as we have in previous surveys by
directly asking about financial difficulties experienced. 
Median personal disposable income after tax in the HIV Futures New Zealand 2 survey was $486 per week. Median
disposable income after tax for the adult New Zealand population from wages and salaries was $524 per week
(New Zealand Income survey June 2007 quarter). 
From this it can be seen that in terms of personal income, PLWHA in New Zealand are economically worse off than
the rest of the population. 
If we compare the financial status of PLWHA in this survey with the first HIV Futures New Zealand survey (Grierson
et al 2002), we can see that the financial situation has improved. Here we compare incomes using the Consumer
Price Index (CPI). The CPI is a measure of “the price change of goods and services purchased by private New
Zealand households. Often used as a measure of inflation, it covers prices for: food; alcoholic; beverages and
tobacco; clothing and footwear; housing and household utilities; household contents and services; health;
transport; communication; recreation and culture; education; and miscellaneous goods and services. The CPI is
produced quarterly from prices gathered in a range of surveys at 15 urban areas” (Statistics New Zealand website). 
$2000$1500$1000$500$0
Respondents’ weekly income after tax
50
40
30
20
10
0
Fr
eq
ue
nc
y
The median personal disposable income in 2001 was $330 and is now $486 per week. This represents an increase
of 47.2%. The CPI in the June Quarter of 2001 was 876.04 and in the June Quarter of 2007 was 1020.00: an increase
of 16.4%. Thus the improvement in financial circumstances is greater than the CPI, but the current situation is still
worse than the rest of the population.
Similarly if we examine adjusted household incomes5, we see a shift from a median of $317 in 2001 to $410 in 2007,
an increase of 29.3%. Household income can provide a fuller picture of the economic wellbeing of individuals as it
takes into account a partner’s income as well.
Expenditure and Debts
Respondents were asked their weekly expenditure on a range of items. The results are shown in Table 75 below.
The total mean expenditure on medication was $53.27 per week with complementary therapies accounting for over
half the total. Mean rental or mortgage costs were $229.72 with the highest costs being in Wellington (mean=
$266.23) and Auckland (mean=$238.37). Food and utilities accounted for around $119 and $77 respectively. 
20.4% of respondents owned their own home, while 18.1% were paying off their home. 15.3% had owned their own
home in the past, but do not currently. 31.0% received a rental subsidy averaging at $90.86 per week (median=
$60). 
Respondents were also asked their current debt burden as one measure of the financial impact of HIV. This
averaged at $56,721 with a median of $10,000. Those who owned their home had a median debt of $8,000
(mean=$87,472), those who were currently paying off their home had a median debt of $84,500 (mean=$113,998),
those in private rental accommodation had a median debt of $6,000 and those in public rental accommodation had
a median debt of $7,427. Only a small percentage (7.5%) had used the services of a financial counsellor in the last
two years. 
TABLE 75 Weekly expenditure on medications and essentials ($NZ)
Mean Median
Rent or mortgage repayments 229.72 175.00
Food 118.92 100.00
Utilities 77.37 50.00
Complementary therapies 34.52 20.00
Other medication 11.96 9.00
Antiretroviral drugs 6.79 5.00
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5 Income is adjusted using Jensen Equivalence scale values (Jensen, 1988) based on the number of adults and children in a household.  
For example two adults with no dependant children require 1.54 times the income of a single adult; two adults with three children require
2.44 times the income of a single person. Thus household incomes are made equivalent to single person incomes by dividing by the
equivalence scale values. The household incomes should therefore be read as if they were for a single person. 
Assessments of Benefits
People receiving a sickness benefit may undergo an assessment by a WINZ Medical Officer. As there has been
considerable community discussion about the impact of these assessments we asked respondents about their
experiences. A total of 34.6% (n=53) of those receiving a benefit in the last two years had received such an
assessment. When asked about the outcome of this assessment, 24 respondents said that it had caused them
distress, while 22 said that the conditions of their benefit had changed. (See Table 76)  Importantly, only 10 people
said that the assessment had clarified their concerns. 
TABLE 76 Consequences of receiving an assessment of benefit from a WINZ Medical Officer
(percentage of those assessed in last 2 years)
Cause you distress 24
Result in changes to the conditions of your benefits 22
Clarify concerns that you had 10
Result in termination of your benefits 2
(Multiple responses possible)
FINANCIAL HARDSHIP
In order to examine the impact of income on other aspects of health and well being we present here a comparison
between the bottom income quartile (i.e. the 25% of participants with the lowest incomes) and the top income
quartile (i.e. the 25% with the highest incomes). This is a method of contrasting financial situations that avoids the
over-complication of examining every small difference. As such, it should be interpreted cautiously. The intention
here is to demonstrate that income is related to health and well being. This is not necessarily a direct causal
relationship. The vast literature on the social determinates of health makes clear that there is interdependence
between health, well being and finances. Lower incomes may mean less access to food, housing, medication etc,
and to poorer health. Poorer health may reduce earning capacity and reduce access to these same things. Below,
we compare these quartiles of income in relation to employment, source of income, health and well being. 
Correlates of Financial Hardship
As can be seen in Table 77 below, those in the lower quartile are much less likely to be in paid employment. This is
unsurprising, but it is important to note that 19% of those in the bottom quartile are actually in paid employment,
this being what many commentators refer to as ‘the working poor’. 
TABLE 77 Employment status by income (percentage of income quartiles)
Bottom Quartile Top Quartile
Employed 18.6 95.9
Not employed 81.4 4.1
Income source is also unsurprisingly related to absolute income. While almost all of those in the top quartile have
an income sourced from salary or superannuation, 83% of those in the lowest quartile have income sourced from
a government benefit or pension. 
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TABLE 78 Income source by income (percentage of income quartiles)
Bottom Quartile Top Quartile
Salary 4.8 87.8
Super/annuity/savings 2.4 2.0
Benefits/pension/social security 83.3 -
Partner 2.4 -
Family/friends 2.4 -
Other 4.8 10.2
When we examine self-reported overall health (Table 79) and well being (Table 80) using these quartiles we can see
a very clear pattern. Those in the bottom quartile of income were far more likely to rate both their health and well
being as fair or poor. Over one third (35%) of those in the bottom quartile rated their health as poor or fair, compared
with only 10% of those in the upper quartile. Similarly, 37% of those in the bottom quartile rated their well-being as
poor or fair, compared with only 8% of those in the top quartile.
TABLE 79 Self-rated heath by income (percentage of income quartiles)
Bottom Quartile Top Quartile
Poor 14.0 -
Fair 20.9 10.2
Good 51.2 40.8
Excellent 14.0 49.0
TABLE 80 Self-rated well being by income (percentage of income quartiles)
Bottom Quartile Top Quartile
Poor 4.7 2.1
Fair 32.6 6.3
Good 44.2 50.0
Excellent 18.6 41.7
Costs
As with the previous survey, we asked respondents about the difficulty they had paying for a range of activities,
goods and services. The results are shown in Table 81 below, with the not applicable responses excluded from the
calculation for each item. The items that most respondents rated as very difficult to pay for were quality of life costs
like travel, going out, entertainment and sport. Those items most likely to be rated as not at all difficult were
medication and support services. Smaller proportions rated food, clothing, utilities and rent as very difficult. The
experience of difficulty in meeting the costs of these items was rarely restricted to one area. That is, when individuals
had difficulty paying for food, they also experienced difficulties with rent, utilities and quality of life items.
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TABLE 81 Difficulty paying costs of items and services
Not at all A little Very difficult 
difficult difficult
Co-payments for medication for HIV/AIDS (n=167)6 76.6 19.8 3.6
Other prescribed medication (n=180) 63.3 26.1 10.6
Medical services (doctor, dentist, etc.) (n=196) 48.0 34.2 17.9
Complementary Therapies (n=108) 50.9 29.6 19.4
Support services (counselling, etc.) (n=76) 69.7 13.2 17.1
Entertainment (theatre, movies, concerts, etc.) (n=174) 48.3 25.3 26.4
Going out (eating/drinking) (n=182) 44.5 26.4 29.1
Sport (exercise, gym, etc.) (n=145) 44.8 28.3 26.9
Recreational drugs (n=126) 50.0 30.3 19.7
Travel/holidays (n=176) 27.8 27.3 44.9
Rent/Mortgage/Housing costs (n=178) 46.6 41.0 12.4
Utilities (telephone/electricity/gas/water) (n=189) 49.7 35.4 14.8
Food (n=198) 53.5 33.8 12.6
Clothing (n=195) 43.6 32.8 23.6
Transport (n=195) 48.2 33.8 17.9
Child care (n=22) 63.6 13.6 22.7
Across all these items those in the lower end of the income distribution were more likely to report difficulty. For
example, comparing the top and bottom quartiles as above, we note differences in the percentage reporting that it
is somewhat or very difficult to pay for: medical services (upper: 28.2%, lower: 64.8%); support services (9.6%,
37.6%); entertainment (20.4%, 75.8%); housing (32.6%, 61.8%); utilities (25.5%, 75.0%); food (19.1%, 74.4%); and
transport (29.8%, 70%). 
DISCRIMINATION
Discrimination is prohibited in New Zealand under provisions of the Human Rights Act 1993. Prohibited grounds for
discrimination include: sex; marital status; religious belief; ethical belief; colour, race, or ethnic or national origins;
disability; age; political opinion; employment status; family status; and sexual orientation. These grounds apply to
a person’s past, present or assumed status and in the areas of: government or public sector activities; employment;
access to education; access to public places, vehicles and facilities; provision of goods and services; provision of
land, housing and accommodation; industrial and professional associations, qualifying bodies and vocational
training bodies; and partnerships. HIV positive status is encapsulated within the grounds of disability, specifically,
“the presence in the body of organisms capable of causing illness”.
Accommodation
3.8% (n=8) of respondents indicated that they had experienced less favourable treatment in relation to
accommodation (1.9% in the last two years). 
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6 Ns refer to the number of participants that identified this as an applicable cost. That is, those selecting “not applicable” or giving no
response are excluded from the percentages reported in that row.
Health Services
HIV
22.4% of respondents had experienced less-favourable treatment at a medical service as a result of having HIV. This
comprised 12.4% (n=26) that had experienced such discrimination in the last two years and 11.0% (n=23) that
experienced this more than 2 years ago. As can be seen in Table 82 many individuals experienced multiple
instances and forms of discrimination. When asked what form this discrimination took, the most common
responses were increased infection control (35.6%) avoidance (34.5%) and confidentiality problems (31.6%). 
TABLE 82 Form of HIV-related discrimination experienced at medical service (number of those
experiencing discrimination)
More than 2 years ago In last 2 years 
(n=23) (n=26)
Increased infection control 10 10
Avoidance 8 10
Confidentiality problems 8 11
Treated last 6 2
Refusal of treatment 7 5
Rushed through 2 7
Harassment 2 3
Abuse 0 1
(Multiple responses possible)
Hepatitis C
Four respondents had experienced less-favourable treatment at a medical service as a result of having hepatitis C.
One of these had experienced such discrimination in the last two years.
Insurance
21.4% of respondents currently had private health insurance and 21.4% also currently had some form of income or
mortgage insurance.
25.9% of respondents indicated that they had experienced less favourable treatment in relation to insurance. This
included 10 respondents who had experienced this discrimination in the last two years. The most commonly
reported example of less favourable treatment was being unable to take out either a specific insurance policy, for
example health insurance, travel insurance or life insurance. Some respondents referred to being generally unable
to take out most insurance policies due to exclusion clauses, while others said they hadn’t bothered to apply for
insurance because they were told they were ineligible. 
Workplace
14.0% of respondents had experienced less-favourable treatment in the workplace as a result of having HIV. This
comprised 5.8% of all respondents that had experienced such discrimination in the last two years and 8.2% that
experienced this more than 2 years ago. When asked what form this discrimination took, the most common
responses were general discrimination.
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INTRODUCTION AND RATIONALE
This section presents an analysis of the survey responses of New Zealand PLWHA of African descent. These
analyses are presented separately for three primary reasons. Firstly, the experience of this population is often
profoundly different to other positive people. The sample presented here includes those who have arrived in New
Zealand as refugees, as part of family reunification provisions or other forms of immigration. The experience of
coming from settings with high HIV prevalence, settings with fundamentally different health care services, the
process of immigration, testing and resettlement and differences in language, culture, and community all mean that
the experience of living with HIV may be profoundly different for this population. In providing guidance for services
such as the African Health Promotion Programme, specific data on this population is useful. Secondly, as will be
seen from what follows, the findings in many sections of the survey are very different for this population. If we were
to include these data in the overall analysis these differences would be masked by the remainder of the data given
the relatively small size of this sample. Thirdly, data on African refugees were presented separately in the first HIV
Futures New Zealand report. To allow meaningful comparison between the two studies it is sensible that this report
present the data in a similar way. 
Caution should be noted, however in direct comparison of this section with that in the previous report. The small
numbers mean that differences are particularly unstable- a slight change in respondent participation can lead to a
large difference for the sample. There are also slight differences in the constitution of these samples between the
two studies. In the first HIV Futures New Zealand survey, only African refugees recruited through the, then, Refugee
Health Education Programme were included in this section. In the current study a broader recruitment effort and
changes in service structure mean that this sample, while largely similar differs from the first. 
As this section reports on a small sample of people, not all analyses can be reported. Where the number of
participants becomes too small to be meaningful or could potentially identify individuals we have not reported
findings. Most analyses in this section are reported by number of people rather than percentages to avoid
overstating the differences. 
DEMOGRAPHICS
This portion of the sample contained 31 (67.4%) women and 15 (32.6%) men. These respondents ranged in age
from 24 to 67 with a mean and a median of 39.0. All of these respondents were heterosexual (100.0%). 
HEALTH
HIV Antibody Testing
Twenty-nine (63%) respondents had taken the test as part of routine health screening.
Pre- and Post-Test counselling/discussion
Eight respondents indicated that they had received pre-test counselling or engaged in an HIV test discussion. Six
reported they were satisfied with the information they received from this person and seven said they were satisfied
with the level of support they received. 
Twenty three (50%) respondents indicated that they had received post-test counselling. Twenty reported they were
satisfied with the information they received from this person and nineteen said they were satisfied with the level of
support they received. 
Current Health Status
Thirty seven (82%) respondents rated their physical health as good or excellent. Thirty-four (76%) rated their well
being as good or excellent. 
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TABLE 83 African respondents’ self ratings of general health status
HEALTH WELL BEING
Frequency Percent Frequency Percent
Poor 2 4.4 3 6.7
Fair 6 13.3 8 17.8
Good 21 46.7 22 48.9
Excellent 16 35.6 12 26.7
CD4 and Viral Load
Almost all respondents had taken a CD4/T-cell test (94%) and a viral load test (87%). Results for PLWHA’s most
recent CD4/T-cell test ranged from 204 to 856 cells/µl with a mean of 511 cells/µl and a median of 500 cells/µl.
Results for PLWHA’s most recent viral load test ranged from below detectable levels to 10,000 copies/ml with a
mean of 804 copies/ml and a median of undetectable. 
HEALTH CONDITIONS
AIDS Defining Illnesses
One respondent said they had been diagnosed with an AIDS defining illness at some point 
HIV/AIDS Related Conditions
Eight respondents indicated that they had experienced an HIV-related illness at some point. 
Other Health Conditions
Seven respondents indicated that they had been diagnosed with a major health condition other than HIV/AIDS. 
Viral hepatitis infection 
One respondent had at some point had hepatitis A, and five had been vaccinated against this virus. None of the
respondents had been diagnosed with hepatitis B, and six had been vaccinated against this virus. Thirty-one
respondents had been tested for hepatitis C, although primarily via an antibody test. One respondent had ever had
hepatitis C. 
Mental Health
In the six months prior to completing the survey, three respondents said they had taken medicines prescribed for
depression. Three reported having taken medicines prescribed for anxiety in the past 6 months and none had taken
anti-psychotic medication. 
HEALTH MAINTENANCE
The most common health-enhancement activity was eating healthily (34 respondents), followed by exercise (28),
sleep (26), and spending time with their partner (12) or family (11). 
Attitudes to Health Management
When asked about health management strategies, almost all participants agreed that exercise; healthy eating and
an optimistic outlook were important or very important strategies.
Complementary Therapies
Six respondents had taken vitamin or mineral supplements and two had used massage in the previous six months.
Prophylaxis
Four respondents had taken prophylaxis for opportunistic infections in the previous six months. 
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Other Health Monitoring
No respondents in this group had taken a bone density test in the previous two years, while nine had taken a fasting
cholesterol test in this period. 27 women ( had undergone a cervical smear (Pap) test, and 26 said they had taken
one in the last twelve months. 
TREATMENTS
Antiretroviral Therapy
Of this sample, thirty respondents (70%) had used ARV at some point, and twenty six (61%) were currently using
these treatments. The most common combination was 2 NRTI-1 NNRTI (10 of those on ARV).
Difficulties of Taking ARV
Overall, twenty six participants currently using antiretroviral treatments nine reported that they had some difficulty
taking them: five indicated they had difficulty remembering to take the drugs on time, four said they had difficulty
transporting medication, six taking a large number of tablets, three had difficulty organising meals around
medication,  and five taking medication in public. Side effects were reported by two of respondents currently using
ARV. 
Attitudes to ARV
Most respondents reported concern over the future efficacy of their treatments. Half (13 out of 26 on ARV) agreed
or strongly agreed with the statement I am worried that in the future my medication will stop working for me. When
asked to respond to the statement Taking tablets gives me an unwanted reminder that I have HIV, nineteen indicated
agreement and six indicated disagreement.
When asked about the circumstances surrounding their commencement of combination therapy, respondents were
most likely to indicate that they were advised to do so by their doctor (22 of the 26 currently on ARV).
When asked how many combinations they believed they still had access to, 24 respondents said they didn’t know
how many combinations they had left. 
Attitudes to Antiretroviral Therapy
Participants in this sample were more likely to report uncertainty in relation to the attitude items in the survey than
other PLWHA. Where participants did feel able to respond, there was a clear reliance on clinical sources of
guidance around managing HIV. These findings can be seen in Table 84.
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TABLE 84 Attitudes to antiretroviral drugs: Number
Strongly disagree Disagree Agree Strongly agree Don’t know
I am healthy now and don’t 11 16 3 12 4
need to use combination 
antiretroviral drugs
People with HIV should start 3 7 6 9 21
using antiretroviral drugs as 
soon as possible
My doctor and I work together 2 2 6 31 4
to find the best treatment for me
My doctor knows a lot more 1 2 11 31 1
about the treatment of HIV than I do.
Combination antiretroviral 5 6 6 7 22
drugs are ineffective
Combination antiretroviral 5 6 9 1 25
drugs are harmful
The side-effects of antiretroviral 3 4 9 6 23
drugs outweigh the benefits
New treatments will be 1 1 13 15 16
developed in time for me to 
gain benefits
HIV treatments will stop me 2 3 10 14 17
dying from AIDS
Combination antiretroviral 4 3 9 9 19
drugs have allowed me to plan 
my life with confidence for the long-term
In addition to these items, respondents were asked to indicate how much they and their friends agreed with the
statement Antiretroviral drugs mean better prospects for most people. Eighteen respondents agreed with this
statement, and eleven believed their friends would agree with it. However, twenty-six respondents responded “do
not know” to this item for themselves and thirty-two “do not know” for their friends. 
Treatment Breaks
In all, ten respondents in this sample had taken a break from antiretroviral medication at some point.
Antiretroviral Resistance
Four respondents who had ever used antiretroviral treatments indicated that they had taken a viral resistance test.
Of those who had resistance testing, all found resistance to one or more antiretroviral drugs and this resulted in a
change of drugs. 
Dosing and Adherence
Twenty-two respondents (75% of those using) were taking ARV twice daily. All of the respondents in this sample,
except one who reported missing a single dose, reported not missing any doses in the two days prior to survey. 
Prescriptions
Twenty-six (57%) respondents obtained their prescription from a specialist in an outpatient clinic. Participants were
most likely to obtain their prescriptions from one place (23 respondents). 15 said obtaining prescriptions was not
difficult and 10 that it was somewhat difficult.
Clinical Trials
Only one participant had participated in a clinical trial for HIV related treatment in the previous two years. 
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Other Medication
Eight respondents were using prescribed medication other than antiretroviral therapies. 
SERVICES
Health Services
Treatment
Hospital-based HIV specialists were the primary providers of HIV specific and general treatment for a large majority
of respondents, while much smaller numbers nominated other types of doctors (see Table 85). Twenty-nine (78%)
respondents said that the doctor they saw for general medical services was the same doctor they saw for HIV-
related treatment. 
TABLE 85 Physician used for general and HIV related treatment: Number
For general For HIV 
treatment specific treatment
HIV specialist at outpatient clinic 25 26
GP 9 2
Doctor at sexual health centre 1 1
GP with high HIV caseload 1 -
HIV specialist in ward at hospital 1 -
Services Used in the Last 6 Months
29 had used a GP, 36 an HIV outpatient specialist, and 3 a dentist. Support services: two reported having used
NZAF counsellor/support worker/therapist, and six a hospital social worker or counsellor 
Other Services
Few participants in this population had used any of the services listed in the survey, either at HIV/AIDS organisations
or at other organisations. One or two respondents indicated that they used services such as peer support, financial
assistance or counselling, four used pharmacy services at an AIDS organisation and three used these organisations
for social contact with other PLWHA. 
Five respondents indicated that there were services they felt they needed but did not have access to, mostly related
to the amelioration of isolation and the provision of social support. 
INFORMATION
Sources
Respondents were asked to nominate from a list of potential sources, those that were important sources of
information on treatments and HIV management, and living with HIV. Clinical services were the most frequently
mentioned in relation to treatments and HIV management information. Few respondents reported accessing
services for information on living with HIV. 
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TABLE 86 Sources of information about treatments and living with HIV (Number)
Information about Treatments/ Information about 
HIV Management Living with HIV
HIV specialist (outpatient) 39 9
GP 32 2
CART 24 4
HIV specialist (inpatient) 7 2
HIV specialist nurse 7 4
Internet 7 7
NZAF staff (treatments-specific) 6 3
Positive Women 6 4
Other HIV/AIDS support organisations 5 1
Publications from HIVAIDS groups 5 4
GP with high HIV caseload 4 3
HIV positive friends 4 3
Pharmacist 4 1
Refugee Health Education Program 4 1
Sexual Health Service 4 3
HIV magazine/newspaper 3 1
Other doctor 3 1
Other nurse 3 2
Publications from other sources 3 3
Body Positive staff (treatments-specific) 2 1
Dentist 2 1
Family planning association 2 -
Family 2 2
NZAF staff (others) 2 3
Partner 2 -
Alternative/Complementary therapist 1 -
Articles in gay press 1 -
Body positive staff (others) 1 1
Haemophilia society 1 -
Injecting drug users organisation 1 -
NZ Prostitutes Collective 1 -
Other friends 1 1
Dietician - 1
(Multiple responses possible)
Information about HIV Treatment and Management
HIV specialists at outpatient clinics were considered to be an important source of information on HIV treatment and
management by the majority of respondents. 
Information about Living with HIV
Respondents nominated very few sources of information around living with HIV. The source selected by the greatest
number of respondents was hospital-based HIV specialists (9 respondents), followed by the internet (7
respondents). 
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Lack of information
Nineteen respondents said that lack of information made it difficult for them to make decisions in certain areas.
Eleven nominated issues around using and changing ARV regimens, thirteen nominated taking breaks from ARV,
eleven issues around having children and eight the management of side effects.
Publications
Few respondents in this sample read HIV publications. Six indicated that they read Collective Thinking and five that
they read Positively Positive.
Involvement with AIDS Organisations
27% had some contact with HIV/AIDS organisations. Of these, seven respondents received newsletters and mail
outs and nine were clients. Of those that had no contact with AIDS organisations, 28 gave the reason I do not want
to be involved, two gave the reason I do not have enough time, one said that they had no transport or were too far
away, and two said they did not know how to join. None of those who were not involved in AIDS organisations said
they felt excluded from them. 
THE SOCIAL WORLD OF PLWHA
Contact with Other PLWHA 
54% of this sample did not personally know anyone else with HIV. 15% had an HIV positive friend and 11% had HIV
positive acquaintances. 24% had either an HIV positive partner or ex-partner (combined). Five respondents had
been involved in the nursing or care of another positive person at some time in the last two years, and 40% have
had someone close to them die from HIV/AIDS. 20% spent at least some time with other positive people. 
Disclosure
Respondents were asked who they had disclosed their HIV status to (see Table 87). All of those who were in a
regular relationship had disclosed to their partner. Within families, people were most likely to have disclosed to
siblings (13%). 17% had not disclosed their HIV status to anyone. 
TABLE 87 People the respondent has disclosed their HIV status to
Percent who 
have disclosed
Partner/spouse 67.4
No-one 17.4
Siblings 13.0
Close friends 10.9
Son/daughter 10.9
Positive friends 6.5
Parents 6.5
Other family members 6.5
Other friends -
Work colleagues -
Neighbours -
People from own ethnic community -
(Multiple responses possible)
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Unwanted Disclosure
Seven respondents said their HIV status had ever been disclosed without their permission at some point. Six said
that this had happened in the last two years. 
Social Support
Participants were most likely to have nominated their health care workers as providing a lot of support (n=38),
followed by their partner/spouse groups (n=20). 
TABLE 88 Social support received from different sources: Number
A lot Some A little None
Health care workers 38 6 - -
Partner/spouse 20 2 - 3
Siblings 5 7 1 5
Religious or spiritual advisor 5 10 10 6
Children 4 8 1 7
HIV positive friends 4 1 1 9
Close friends 3 7 13 5
Parents 3 2 - 2
Family 3 14 3 10
Pets 2 3 2 8
PLWHA groups 1 - - -
Doctor 1 1 2 2
Counsellor 1 - 1 -
Other friends 1 8 14 5
Volunteer carer - 1 - 5
Attitudes to HIV status
When asked to respond to the statement As long as I am well I prefer not to think about HIV/AIDS, 38 indicated
agreement and 7 disagreement. 
When asked to respond to the statement Life has become more meaningful since I became HIV positive, 30
indicated agreement and 13 disagreement. 
Planning for the Future
53% of respondents indicated that they planned only one day at a time, 16% a few months ahead, 2% one year
ahead, 13% five years and 16% ten or more years. 64% said this had not changed in the previous two years. 
RELATIONSHIPS AND SEX
Relationships
When asked if they were currently in a regular relationship, 54% said they were. Of those, 43% (n=9) reported that
their partner was also HIV positive. All of those with a regular partner had told their partner that they were HIV
positive. Most respondents reported consistent condom use with regular partners. 
Casual Partners
Participants in this group reported very little casual sex. Due to the small numbers involved we will not report data
on this here. 
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Legal Issues around disclosure of HIV status
Participants were most likely to indicate either agreement with the two legal statements, or that they were uncertain. 
TABLE 89 Attitudes to legal issues around disclosure: Number
Strongly disagree Disagree Agree Strongly agree Don’t know
Currently it is legally OK for 14 2 6 9 14
someone to use a condom 
for anal or vaginal sex and not 
to tell their partner about HIV 
status
Currently it is legally OK for a 18 3 4 5 15
person to disclose their HIV 
status to a partner and then 
not use a condom for anal or 
vaginal sex
The current legal situation 4 7 6 23 1
about disclosure about HIV 
status has limited my ability 
to form new relationships
Children
72% (n=33) of these respondents had children, 21 women and 12 men. 39.1% (14 women and four men) had
dependent children living with them. When asked about future plans, 12 said they were not planning to have
children, 9 (8 women and one man) that they have decided to have a child/children in the future, 2 that they are
currently trying to conceive or get pregnant, and 4 that they have thought about it but I haven’t decided. One
respondent said they did not have enough information to make a decision.
HOME, WORK AND MONEY
Accommodation
Twenty-nine respondents (63%) were living in public rental accommodation, while twelve were living in private rental
accommodation. Four either owned or were purchasing a home. 69.6% of respondents stated that their
accommodation was suitable for their current needs. Of those who said their accommodation was unsuitable
(N=13), the main reasons given were the poor condition of housing (8), that it had inadequate facilities for carers
(5), that it was inadequate for their current state of health (5), that it was too small (4), and was too expensive (4).
Three respondents had ever changed their accommodation as a result of having HIV/AIDS. 
Employment
Twenty four respondents (52.2%) were currently employed, with eighteen being in full-time work and six in part-time
work. Most respondents (34) reported no change in their career plans at time of diagnosis, as a result of the
ongoing impact of HIV (29) or on commencement of ARV (19). Of those who have worked, one respondent had
stopped work for reasons related to HIV at some point. 
When asked what difficulties they experience around confidentiality at work, 13 of the 24 said they have experienced
no problem in this area, although there were no respondents in this group that did not attempt to keep their status
confidential (see Table 90). 
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TABLE 90 Difficulties with HIV status confidentiality in the workplace
No problems 13
Difficulty keeping and taking medication 8
Explaining absences from work 4
Gossip 3
Visible signs of illness 1
Other  1
I do not try to keep my HIV status confidential -
(Multiple responses possible)
When asked how many people in the workplace knew that participants were HIV positive, 21 of the 24 working said
no-one knew and the remaining three that a few people knew. Nineteen of the respondents reported that their work
capacity was not affected by HIV/AIDS.
Finances
The source of income of the survey respondents is shown in Table 91 below. Twenty-one were receiving a salary
and seventeen had a government pension or benefit as their main source of income. 
TABLE 91 Primary source of income: Number
Salary 21
Benefits/pension/social security 17
Partner supports me 2
Other 1
The median weekly in-hand income for respondents was $380. The partners’ median weekly income was $630. The
total mean expenditure on ARV medication was $8.50 per week, $12.8 on other medication and $24 per week on
complementary therapies. Mean rental or mortgage costs were $172. Food and utilities accounted for around $145
and $69 respectively. Personal disposable income after tax for this sample had increased by 93% since the previous
survey, compared to an increase in the CPI of 16%. Median income, however, was still lower than the remainder of
the sample, and the New Zealand population. 
Four respondents owned their own home, while 41 were paying off their home. One respondent was receiving a
rental subsidy. 
Assessments of Benefits
Seven of the thirty-nine respondents receiving a benefit in the last two years had received an assessment. When
asked what this experience resulted in, four said that their benefit was terminated.
Costs
Participants in this group reported higher rates of difficulty in paying for the costs of items in all categories than other
PLWHA. 
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TABLE 92 Difficulty paying costs of items and services (Number: Participants of African Descent)
Not at all difficult A little difficult Very difficult
Co-payments for medication for HIV/AIDS 9 13 3
Other prescribed medication 9 8 6
Medical services (doctor, dentist, etc.) 6 7 25
Complementary Therapies 4 2 1
Support services (counselling, etc.) 2 1 3
Entertainment (theatre, movies, concerts, etc.) 4 4 26
Going out (eating/drinking) 6 3 30
Sport (exercise, gym, etc.) 8 4 28
Recreational drugs - - 1
Travel/holidays 2 3 33
Rent/Mortgage/Housing costs 8 10 22
Utilities (telephone/electricity/gas/water) 5 4 31
Food 8 4 29
Clothing 6 7 28
Transport 6 9 26
Child care 4 2 3
DISCRIMINATION
Accommodation
Two respondents indicated that they had experienced less favourable treatment in relation to accommodation, both
in the last two years. 
Health Services
Six respondents had experienced less-favourable treatment at a medical service as a result of having HIV, all in the
last two years. When asked what form this discrimination took, the most common responses were being rushed
through (5), additional infection control (3), and breaches of confidentiality (3). One respondent reported refusal of
treatment. 
Insurance
Five respondents currently had private health insurance and three currently had some other form of income or
mortgage insurance. Six respondents indicated that they had experienced less favourable treatment in relation to
insurance. 
Workplace
Two respondents had experienced less favourable treatment in the workplace as a result of having HIV, both in the
last two years 
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CONCLUDING
COMMENTS
We hope that this report has provided a comprehensive overview of the multiple aspects of lives of New Zealand
PLWHA. We have presented findings from the study that cover health and treatments, service engagement,
relationship to HIV community, sex and relationships, housing, employment, finances and discrimination. These
analyses have implications, both broad and specific for the response to the HIV epidemic in New Zealand. The
vision of the authors of this report is that those with responsibilities in each of these areas take serious note of these
findings and the implications for their practice. The publication of these findings represents a sharp and critical
opportunity for an assessment of the New Zealand response and the ways in which it is serving or disadvantaging
people living with HIV/AIDS. Challenges clearly still remain for people living with HIV in New Zealand, even though
we note clear improvements since the first survey. We ask that policy makers, legislators, funding agencies, service
providers, clinicians, support groups and individuals take advantage of this report and respond within their own
ambit to work toward improving the place of PLWHA in New Zealand society. This report does not make direct
recommendations on the changes to policy and practice that these findings point to. We ask you to take up that
responsibility. We ask that you actively engage with the findings of this report and to do justice to the contribution
of people living with HIV that is evidenced here. 
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APPENDIX A: 
METHODS AND
INSTRUMENT
This section describes the research design, method of recruitment, development of the survey instrument,
sampling issues and data analysis.
THE SURVEY INSTRUMENT
HIV Futures New Zealand 2 was an anonymous, cross-sectional survey of a sample of people living with HV/AIDS.
The survey ran from February until August 2007. The survey was available as both a self-complete, mail back survey
and as an on-line survey. On-line surveys have been used successfully in HIV research in New Zealand (for example
Saxton et al 2007) and we have used online methodologies to collect health information from PLWHA and GLBTI
people in Australia (Pitts et al., 2006; Grierson et al, 2006, Hillier et al., 2005). We hoped that by offering HIV Futures
NZ online we would provide an easier way for the usual demographic of respondents to complete the survey and
also allow us to access harder to reach PLWHA. The on-line survey was accessed through the website
www.hivfutures.org.au. The site was hosted by Demographix.co.uk, an experienced commercial provider of web-
based surveys with excellent attention to the issue of security and privacy. 
DESIGN
The instrument was based in large part on the first HIV Futures New Zealand survey with some modifications based
on the most recent Australian survey (Grierson et al, 2006), and modifications reflecting changes in issues of
concern, health service structure, community sector structure and clinical issues. 
The survey consisted of 250 items organised into eight sections: demographics; accommodation; health and
treatments; services and communities; sex and relationships; employment; recreational drug use; and finances.
Each section included an explanation of the purpose of the items. Most items in the survey were closed-coded with
either single or multiple response options. ‘Other’ categories were included for most items to ensure that significant
experiences of living with HIV were not excluded. There was a number of attitude/ belief items scored using a four-
and five-point Likert scales. There were also write-in and open-ended items. The online survey used identical
wording to the paper survey and contained exactly the same items, however the online survey provided users with
drop-down menus for some items, such as numbers, years and months. These were included in order to ensure
relatively clean data. The online survey also had a number of skips built into it so that respondents did not have to
see items that were not relevant to them, for example respondents who were not taking antiretroviral treatments did
not have to see the questions about these treatments. 
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Completed paper surveys were returned in a reply-paid envelope to the Living with HIV program at ARCSHS.
Respondents were also able to add their contact details to the program mailing list to receive reports and to
participate in further research by completing an additional form and sending it in a separate envelope. On-line
surveys were able to be saved and re-opened by respondents so that they could be completed in their own time.
Completed surveys were submitted online and stored by demographix.co.uk. Respondents completing the survey
online were also able to provide researchers with their contact details by filling in and submitting a separate form,
which was stored in a database separate from the survey data. 
RECRUITMENT AND SAMPLING
As the survey was anonymous and as multiple recruitment strategies were employed a simple response rate cannot
be calculated. Recruitment took place using a set of methods in order to reach a diverse population of HIV positive
people. This approach meant that some participants received multiple copies of the survey from different sources.
Recruitment was also combined with a promotion strategy that increased community awareness of the research
and its utility. The inside front cover of the paper survey also contained the link to the online survey so that each
participant receiving a paper copy was also informed about the availability of the on-line survey.
1. Direct distribution
Copies of the survey could be directly requested by potential participants and mailed either from the Australian
office or from NZAF. We did not utilise the mailing list collected as part of the first HIV Futures New Zealand survey
for this project, as it had been five years since this was compiled and many contact details would have changed.
Surveys were also mailed out as an insert with Collective Thinking.
2. Promotion and Marketing 
Paid Advertising
The survey was advertised in a number of gay and HIV publications with distribution around the country. Banner
ads with a direct link to the on-line survey were placed on websites that reached gay communities.
Advertising through community organisations
The survey was promoted extensively through community organisations. Advertisements, articles and news items
were placed in community newsletters, banner ads were placed on community websites and promotional post-
cards and reception cards were placed and reception desks. 
3. Community sites
In addition to advertising the survey, community organisations were involved in promoting the study by mailing the
survey to members accompanied by a covering letter from the organisation explaining the purpose of the study,
explaining the value of the research, and encouraging participation. The survey forms were made available on-site
at community organisations. These organisations also distributed copies of the survey to sites and venues they felt
were appropriate and with whom they have ongoing relationships. Special events were held at some community
organisations to encourage people to complete the survey with the project officer on site to answer any questions.
Staff at some organisations also assisted people to complete surveys. The survey was also promoted at staff and
volunteer meetings. 
4. Clinical sites
Surveys were made available and promoted through posters and postcards at a range of clinical sites around the
country. These included HIV specialist services, hospital HIV services, sexual health services and general
practitioners. Each service tailored the promotion and distribution of surveys to suit their specific model of practice. 
Table 93 below gives the sources identified by respondents as the primary site that they obtained the survey, or
information about the survey. The on-line sample is shown separately from the paper sample. It should be noted
that many participants would have obtained copies of the survey and information about the research from multiple
sources.
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TABLE 93 Data on primary site of survey collection
Paper On-line Combined
Completed a previous HIV Futures Survey 9.6 5.3 8.5
Mail-out from HIV/AIDS organisation 34.3 35.1 34.5
Picked up a copy at HIV/AIDS organisation 3.4 12.3 5.5
Picked up a copy at Medical Centre or Hospital 18.0 - 13.6
Positive Women’s Organisation 5.1 - 3.8
Gay newspaper/magazine 0.6 7.0 2.1
Recruited by researcher 1.1 8.8 3.0
Postcard in medical setting - 8.8 2.1
From an interpreter 16.9 - 12.8
Other 11.1 17.5 25.5
ON-LINE SURVEY
Around one-fifth of the sample completed the survey on-line. The on-line and paper samples were similar, however
the on-line sample was more likely to be male, gay, employed, to have a university degree, to be taking treatments
and to have an undetectable viral load. When combined, the sample was similar to the first HIV Futures New
Zealand sample. 
TABLE 94 Comparison of online sample and paper survey sample
Variable Paper Online Combined Futures NZ1
N (%) 203 (77.8) 58 (22.2) 261 226
Sex(%) 
Male 70.6 93.1 75.7 75.7
Female 28.9 6.9 23.9 23.9
Age, years (Mean, range) 46.0 (23-75) 44.1 (24-88) 45.6 (23-88) 40.5 (18-68)
European/Pakeha 64.5 70.7 65.9 66.8
Sexuality:
Gay/lesbian 55.6 76.8 60.2 57.4
Heterosexual 37.4 14.3 32.3 35.6
Bisexual 5.6 7.1 5.9 6.0
Employment status: Employed: 56.4 73.7 61.7 53.0
Residential location: Auckland 53.7 56.9 54.4 50.2
Education: University degree 23.2 43.9 27.7 16.7
Use of treatments: 
Currently taking 68.0 80.7 70.8 64.2
Taken in the past 7.0 5.3 6.6 21.9
Never taken 25.0 14.0 22.6 13.9
Most recent CD4 count, 
cells/µL (Median) 487.5 405.0 480 445
Most recent viral load 
copies/ml (Median) Undetectable Undetectable Undetectable 371.2
Most recent viral load 
undetectable (%) 60.4 77.3 63.7 55.9
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Year tested HIV positive Paper Online Combined Futures NZ1
Before 1985 3.0 - 2.3 17.5
1985-1989 9.9 13.8 10.8 23.1
1990-1994 12.9 15.5 13.5 23.1
1995-1999 23.3 17.2 21.9 28.8
2000-2004 33.2 27.6 31.9 7.5
2005 on 17.8 25.9 19.6 -
We were also interested in the extent to which we were accessing HIV positive people who had participated in
previous HIV Futures Surveys and other research projects (see Table 95). 
TABLE 95 Data on previous research involvement
Paper On-line Combined
HIV Futures NZ1 30.5 29.3 30.3
Australian HIV Futures surveys 2.5 - 1.9
GAPSS 2002 2.5 6.9 3.4
GAPSS 2004 2.5 10.3 4.2
GAPSS 2006 2.5 1.7 2.3
GOSS 2006 2.5 8.6 3.8
Justification of Study Methodology
HIV Futures is a cross-sectional study of a sample of HIV positive people. A cross-sectional study is one in which
a new sample is collected on each occasion. While a proportion of the sample may have completed the previous
surveys, the responses for each survey are not formally linked, so that direct comparison between individuals’
responses over time is not possible. The cross-sectional methodology was chosen for the following reasons. 
The HIV Futures Surveys are anonymous. HIV/AIDS remains a sensitive issue for many PLWHA. Our previous
research and that of our colleagues tell us that PLWHA still experience stigma and discrimination. Allowing the
survey to be completed anonymously helps to allay PLWHA’s concerns that information about their HIV status and
the other issues addressed in the survey may be compromised. 
The survey is self-complete. This means that PLWHA can complete the survey in a setting that is comfortable and
safe for them and in their own time. Feedback from participants during this study indicated that some people
completed the survey over a number of days or weeks, and that individuals consulted their medical practitioners
and other records to verify some of the details included in the survey.
Fourth, the population of HIV positive people is constantly evolving. A cross-sectional survey allows us to include
newly HIV positive individuals as well as those who have been positive for some time. These groups may have an
overall similar experience of living with HIV, but the differences between them can be profound. 
There are also certain limitations associated with the recruitment method used. Caution must therefore be exercised
in the application of the findings of this research to individuals who are less likely to be included in the sample, such
as people with limited literacy, people of non-English speaking background, and those who are particularly
geographically or socially isolated. We have taken a range of measures to address these issues. For example,
participants were offered the option of completing the survey over the telephone either directly with the researchers
using a free call number, or with service providers. Surveys were also completed with the assistance of service
providers or community agency workers for those with literacy problems, people who required assistance with
translation, or those with physical impairment. The combination of clinical and community setting for study
recruitment was intended to optimise access to the study. This means that people are not disadvantaged from
entering the study if they are not currently using anti-retroviral therapies or not currently in contact with one of the
main HIV treatment providers. 
Nevertheless it must be acknowledged that this methodology will never be appropriate for some members of the
PLWHA community. This is particularly so for those from culturally and linguistically diverse backgrounds who may be
marginalised even within their own communities, and those for whom invisibility is the key to their continuing safety. 
It cannot be stressed strongly enough that no piece of research should be used in isolation. Each study gives a
different perspective on the HIV epidemic, and collectively they lead to a greater understanding of the dynamics of
the epidemic and the issues affecting PLWHA. 
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Consultations
A broad range of consultations was undertaken prior to finalising the HIV Futures New Zealand 2 survey instrument.
These were conducted with clinical services, HIV services, community based organisations representing broad and
specific constituencies of PLWHA and other researchers. Ongoing consultation with these groups and individuals
occurred throughout data collection, analysis and report writing. 
ANALYSIS
Statistical comparisons including ANOVA and chi-square have been employed in the analysis of the data, although
for clarity the details of these are not included in this report. All significant differences reported have a probability of
at least a=0.05.
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